Peter Psaltis

Research Interests

Cardiology Cardiovascular Medicine and Haematology Cardiovascular System & Hematology Cardiac, Respiratory and Vascular Health Immunology and Infection Regenerative medicine (incl. stem cells) Biomedical Engineering

Prof Peter Psaltis

Grant-Funded Research Professor

School of Medicine

College of Health

Eligible to supervise Not eligible, but is currently at capacity - email supervisor to discuss availability.

Prof Peter J Psaltis (MBBS (Hons), PhD, FRACP, FCSANZ, FESC)
 
Professor Peter Psaltis is an academic Interventional and Preventative Cardiologist who holds a Level 3 National Heart Foundation Future Leader Fellowship and Faculty positions at the Central Adelaide Local Health Network, University of Adelaide and South Australian Health and Medical Research Institute (SAHMRI). He is the co-Deputy Director of SAHMRI, co-leads its largest research department (Lifelong Health Theme) and leads its Heart and Vascular Health Program. Concurrently, he is Head of Interventional Cardiology at the Royal Adelaide Hospital. Among national and state leadership positions, Peter is a Board Director of the Australian Cardiovascular Alliance and co-Chair of its Coronary Artery Disease Clinical Theme, past-President of the Australian Atherosclerosis Society, co-Chair of the South Australian Aboriginal Heart and Stroke Leadership Group, and co-Chair of the Heart Foundation’s South Australian Cardiovascular Research Network.
 
Peter has expertise across all three disciplines of basic, translational, and clinical research and leads bench-to-bedside projects spanning topics of developmental macrophage biology, vascular stem cells, inflammatory regulation of atherosclerosis, pharmacological modification of atherosclerosis, coronary plaque imaging, the modelling of biomechanical forces in coronary arteries and cardiometabolic disease. He has received >$22 million of peer-reviewed grant funding and received the 2021 NHMRC Marshall and Warren Award for Innovation. As of early 2025, Peter has published >240 manuscripts and book chapters. His research has global impact and reach, and he ranks in the top 0.05% worldwide for productivity and impact in coronary artery research over the last 5 years, also receiving numerous national and international awards for his scientific discoveries. Peter has supervised 10 EMCRs and graduated 13 PhD (4 as principal supervisor, all Dean’s commendation, including one Doctoral Research Medal) and 12 Hons students (all first class).
 
Prof Psaltis’ impact’s reach and significance are evidenced by >275 papers, cited >10,000x from 134 countries and 28 disciplines, with citations in 66 patents, 26 clinical guidelines from 9 countries and 21 policy statements from 6 countries. Public outreach includes 176 news stories from 111 global outlets in 22 countries, 9 Wikipedia pages and 1,602 “X” posts from 76 countries.

Vision 

Prof Psaltis’ vision is to replace today’s uniform, reactive approach to secondary prevention after MI with one that is precise, mechanism-informed and personalised to each patient’s residual atherosclerotic risk.


Research Overview

Coronary artery disease (CAD) is the leading cause of death worldwide, costing $150 billion/year. Over the last decade, Prof Psaltis’ bench-to-bedside program has made world-first discoveries of new cellular1,2, molecular3,4 and biomechanical5 mechanisms underlying atherosclerosis, and provided key insights on patterns of coronary disease6-8 and post-MI outcomes9-12. Peter’s work has also helped define the responsiveness of coronary plaque to different antiatherosclerotic therapies13-15.

Three themes of his work’s transformative impact include groundbreaking findings of:

  1. SCAD (spontaneous coronary artery dissection) as a non-atherosclerotic cause of MI 6,16,17;

  2. Anti-atherosclerotic properties of the anti-inflammatory drug, COLCHICINE 15,18-20; and 

  3. Ability of PCSK9 inhibitors to stabilise and regress coronary plaque after MI14,21-24.

Peter is also interested in atherosclerotic plaque buildup in arteries following heart attacks. Despite current care standards, heart attack survivors are at high risk of repeat, life-threatening events from continued arterial plaque build-up. His research aims to transform management after a heart attack by using CT imaging to visualise remaining plaque, monitor how it changes over time, and study how it relates to inflammation. This will allow us to better predict an individual’s risk, reduce repeat events, and develop novel treatments 4,8,25. 

*Psaltis first/last author. +Psaltis author.

1. *Toledo-Flores D, et al. Vasculogenic properties of adventitial Sca-1(+)CD45(+) progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Sci Rep. 2019;9:7286. 

2. *Williamson AE, et al. Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nat Commun. 2024;15:7097. 

3. *Fernando S, et al. Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. FASEB J. 2022;36:e22154. 

4. *White JB, et al. Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction. Atherosclerosis. 2025;408:120421. 

5. *Carpenter HJ, et al. On the nonlinear relationship between wall shear stress topology and multidirectionality in coronary atherosclerosis. Comput Methods Programs Biomed. 2023;231:107418. 

6. *Rashid HN, et al. Incidence and characterisation of spontaneous coronary artery dissection as a cause of acute coronary syndrome--A single-centre Australian experience. Int J Cardiol. 2016;202:336-338. 

7. *Bogana Shanmugam V, et al. Outcomes After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Caused by Ectatic Infarct Related Arteries. Heart Lung Circ. 2017;26:1059-1068.

8. *Baumann AAW, et al. Prevalence and real-world management of NSTEMI with multivessel disease. Cardiovasc Diagn Ther. 2022;12:1-11. 

9. +Spoon DB, et al. Trends in cause of death after percutaneous coronary intervention. Circulation. 2014;129:1286-1294. 

10. +Spoon DB, et al. Prediction of Cardiac and Noncardiac Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2015;8:e002121. 

11. *Nguyen MT, et al. Thirty-Day Unplanned Readmissions Following Elective and Acute Percutaneous Coronary Intervention. Heart Lung Circ. 2023;32:619-628. 

12. +Nguyen MT, et al. High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use. JAMA Netw Open. 2024;7:e2438541. 

13. +Nicholls SJ, et al. Effect of Serial Infusions of CER-001, a Pre-beta High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018;3:815-822. 

14. *Nicholls SJ, et al. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in StatinTreated Patients Following Myocardial Infarction. JACC Cardiovasc Imaging. 2022;15:1308-1321. 

15. *Psaltis PJ, et al. Optical coherence tomography assessment of the impact of colchicine on nonculprit coronary plaque composition after myocardial infarction. Cardiovasc Res. 2025;121:468-478

16. *Franke KB, et al. Systematic review and meta-analysis of the clinical characteristics and outcomes of spontaneous coronary artery dissection. Int J Cardiol. 2021 Jan 1;322:34-39. 

17. +Dang QM, et al. The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence. Eur Heart J. 2025 Jun 2;46(21):2012-2023.

18. *Schwarz N, et al. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. FASEB J. 2023 Apr;37(4):e22846. 

19. *Montarello NJ, et al. Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study. Cardiovasc Drugs Ther. 2022 Dec;36(6):1175-1186.

20. *Psaltis PJ, et al. Persistent inflammation after myocardial infarction: Elevated IL-6 associates with impaired coronary plaque stabilisation despite optimal therapy. Eur J Prev Cardiol. 2025 Sep 1:zwaf563. 

21. *Nicholls SJ, et al. Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. Cardiovasc Diagn Ther. 2021 Feb;11(1):120-129.

22. *Nicholls SJ, et al. Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. JACC Cardiovasc Imaging. 2023 Jan;16(1):130-132.

23. +Fujino M, et al. Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS. Atherosclerosis. 2025 Apr;403:119145. 

24. +Di Giovanni G, et al. Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. Eur J Prev Cardiol. 2025 Apr 8:zwaf211. 

25. *Allahwala M, et al. Type 2 Diabetes and Acute Myocardial Infarction: Insights into Admission Complexity and Readmission Rates in a Tertiary Centre. Heart Lung Circ. 2025 Sep 11. 

 

Media Engagement

 

Projects available for Honours 2026 and 2027

Project 1

Title: Human EndoMac progenitor cells - Isolation and characterisation

Description: Blood vessel formation is essential for tissue development, growth, and repair. Macrophages and endothelial cells play interlinked roles in blood vessel formation. In adult tissues, these cell types are thought to originate independently of each other. We have discovered unique adult stem cells in mouse tissues termed Endothelial-Macrophage (EndoMac) progenitor cells that give rise to both macrophages and endothelial cells and contribute to blood vessel formation after tissue injury. We have found analogous cells in human tissues. This project aims to isolate, characterise, and investigate the properties of human EndoMac progenitor cells, for therapeutic manipulation.                    

 

Project 2

Title: Investigating mechanisms underlying pathogenesis of scleroderma-related vasculopathy

Description: Scleroderma, a chronic autoimmune disorder, is characterised by inflammation, vasculopathy and fibrosis of the skin and internal organs. Vasculopathy can affect both micro- and macro- blood circulation, resulting in blue fingertips or Raynaud’s phenomenon, fingertip ulcers, and lung and renal complications. Injury and dysfunction of endothelial cells, the building blocks of blood vessels, are thought to trigger vasculopathy of the skin that manifests as Raynaud’s phenomenon but the causes are poorly understood. This project will investigate the role of cellular senescence and autophagy in endothelial cell injury/ dysfunction and fingertip ulcers in scleroderma, to identify biomarkers for early diagnosis and disease management.   

 

Supervisors: Peter Psaltis, Shiwani Sharma, Sanuri Liyanage

Projects available for: Honours and Masters

Location: South Australian Health and Medical Research Institute, Level 6 South

Research projects start: Semester 1 and 2


Most Influential Publications

40% of Psaltis’ papers are first/senior author, and since 2022 these have had mean FWCI 2.9. In the past 2 years, he has produced 72 papers and >3,600 citations, underlining accelerating trajectory and intellectual leadership. He is in the Stanford/Elsevier Top 2% World Scientist Rankings.

Publication 1.

Citation: PSALTIS PJ*, Nguyen MT, Singh K, Sinhal A, Wong DTL, Alcock R, Rajendran S, Dautov R, Barlis P, Patel S, Salagaras T, Marathe JA, Bursill CA, Montarello NJ, Nidorf SM, Thompson PL, Butters J, Cuthbert AR, Yelland LN, Ottaway JL, Kataoka Y, Di Giovanni G, Nicholls SJ. “Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.” CARDIOVASCULAR RESEARCH 2025; 121:468-78. doi: 10.1093/cvr/cvae191

Explanation: Reported results of investigator-led COCOMO-ACS trial (9 sites) that used optical coherence tomography to study colchicine’s effects on coronary plaque after myocardial infarction (MI). The key finding was that colchicine required >16 months duration to stabilise plaque and reduce rupture. Editorialised by leading trialist Tardif (Canada), included in 8 meta-analyses (e.g., EHJ 2025, PMID 40314333) and EU statement paper (PMID 41206215) as explaining colchicine’s mixed effects in Phase 3 trials. Led to me giving 11 invited talks (e.g., Greece, Hong Kong), 2 commentaries (Nat Cardiovasc Res; Eur J Prev Cardiol), and an engineering collaboration that supported 1 patent and plaque analytics start-up (Corcillum).

 

Publication 2.

Citation: Schwarz N, Fernando S, Chen YC, Salagaras T, Rao SR, Liyanage S, Williamson AE, Toledo-Flores D, Dimasi C, Sargeant TJ, Manavis J, Eddy E, Kanellakis P, Thompson PL, Tan JTM, Snel MF, Bursill CA, Nicholls SJ, Peter K, PSALTIS PJ*. “Colchicine exerts anti-atherosclerotic and plaque-stabilizing effects targeting foam cell formation.” FASEB JOURNAL 2023; 37:e22846. doi: 10.1096/fj.202201469R

Explanation: One of the first studies to show anti-atherosclerotic properties of colchicine in two mouse models. Identified new mechanisms in plaque-forming macrophages: e.g., inhibition of cholesterol crystal-induced NLRP3 inflammasome activation; reduced foam cell formation; increased cholesterol efflux.

Cited in Nat Rev Cardiol, 2xNat Cardiovasc Res, 2xEur Heart J, 2xCardiovasc Res as providing key insights into NLRP3 and foam cell biology, and foundational mechanistic evidence that underpins clinical use of colchicine in atherosclerosis. Directly informed studies exploring colchicine delivery by nanoparticles (PMID 38037046) and in proinflammatory settings (e.g., clonal haematopoiesis, PMID 39212933) and my COCOMO-ACS trial (PUBLICATION 1).

 

Publication 3.

Citation: Williamson AE, Liyanage S, Hassanshahi M, Dona MSI, Toledo-Flores D, Tran DXA, ….Harvey NL, Drummond GR, Vinh A, Chandrakanthan V, Misra A, Neufeld Z, Tan JTM, Martelotto L, Polo JM, Bonder CS, Pinto AR, Sharma S, Nicholls SJ, Bursill CA, PSALTIS PJ*. “Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta.” NATURE COMMUNICATIONS 2024; 15:7097. doi: 10.1038/s41467-024-51637-7

Explanation: Reports discovery of EndoMac progenitor cells in arterial adventitia. These embryonically derived, self-renewing cells are bipotent for macrophages and endothelium and drive local inflammation and neovascularisation, providing rigorous evidence for a century-old haemangioblast hypothesis and a new paradigm for arterial biology.

Cited by Nature Protocols and Nature Immunology papers, and by stem cell experts (e.g., Porello) as opening new avenues for cell therapy and tissue repair. Findings received broad attention, attracting >16,000 views, generated 21 news stories globally (e.g., COSMOS, Yahoo!, MSN) and a new Wikipedia page.

 

Publication 4.

Citation: Nicholls SJ, Kataoka Y, Nissen SE, Prati F, Windecker S, Puri R, Hucko T, Aradi D, Herrman JR, Hermanides RS, Wang B, Wang H, Butters J, Di Giovanni G, Jones S, Pompili G, PSALTIS PJ*. “Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction.” JACC CARDIOVASCULAR IMAGING 2022; 15:1308-21. doi: 10.1016/j.jcmg.2022.03.002

Explanation: Reported the primary results of the HUYGENS trial (27 sites, 7 countries) - the first study to show using intracoronary imaging that intensive cholesterol lowering with the PCSK9 inhibitor evolocumab, started early after MI, stabilises coronary plaques beyond what statins achieve alone.

This was presented as a late-breaking trial at the ESC ASM and editorialised by world leaders Stone and Narula (USA). Cited by the 2025 Lancet Commission on coronary artery disease, 2023 and 2025 ESC, 2025 ACC/AHA and 2025 Australian guidelines, it is recognised as defining how plaques heal after MI and helped transform clinical practice by providing mechanistic rationale for lowering post-MI cholesterol targets. Its findings also informed ongoing EVOLVE-MI and AMUNDSEN Phase 3/4 trials.

 

Publication 5.

Citation: Nicholls SJ, Andrews J, Kastelein JJP, Merkely B, Nissen SE, Ray KK, Schwartz GG, ……….Di Giovanni G, Pisaniello AD, Scherer DJ, PSALTIS PJ*, Butters J. “Effect of serial infusions of CER-001, a pre-β High-Density Lipoprotein mimetic, on coronary atherosclerosis in patients following acute coronary syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A randomized clinical trial.” JAMA CARDIOLOGY 2018; 3:815-22. doi: 10.1001/jamacardio.2018.2121

Explanation: International randomised trial (272 patients, 4 countries, 34 sites) that used intracoronary imaging to show that infusion of a new high-density lipoprotein-cholesterol (HDL-C) mimetic has no effect on residual plaque in statintreated patients post-MI.

Editorialised by leading HDL expert, Rader (USA) and extensively referenced in leading journals (e.g., NEJM, Lancet, 5xNature Reviews, 3xJACC, Circulation, 2xCirculation Research). Findings provided critical mechanistic insights to explain why HDL-C-promoting therapies consistently fail to prevent ischaemic events in Phase 3 trials (e.g., AEGIS-II) and reinforce why they are not suitable for clinical practice.

 

Publication 6.

Citation: Nguyen MT, Fernando S, Schwarz N, Tan JT, Bursill CA, PSALTIS PJ*. “Inflammation as a therapeutic target in atherosclerosis.” JOURNAL OF CLINICAL MEDICINE 2019; 8:1109. doi: 10.3390/jcm8081109

Explanation: Invited state-of-the-art review discussing pathways of inflammation that mediate atherosclerosis and its complications, bench-to-bedside evidence for established and new anti-inflammatory therapies, biomarkers and upcoming clinical trials.

Awarded 'Best Cover Paper' for the Journal of Clinical Medicine. Attracted >20,000 views and 22-47 cites/year since 2020 across 18 disciplines. Used as a foundational reference to shape the academic framing of anti-inflammatory therapies in cardiovascular disease, including natural products, long non-coding RNA, colchicine, IL-6 inhibitors, PCSK9 inhibitors, GLP-1R agonists and nanoparticles, as well as studies of biomarkers and plaque imaging.

 

Publication 7.

Citation: Li J, Montarello NJ, Hoogendoorn A, Verjans JW, Bursill CA, Peter K, Nicholls SJ, McLaughlin RA, PSALTIS PJ*. “Multimodality intravascular imaging of high-risk coronary plaque.” JACC CARDIOVASCULAR IMAGING 2022; 15:145-59. doi: 10.1016/j.jcmg.2021.03.028

Explanation: Expert review article published in the leading cardiology imaging journal, providing a comprehensive and forwardlooking update on new developments in imaging to diagnose high-risk coronary plaques.

A widely used reference by world experts across different imaging modalities (e.g., Budoff, Narula, Jiang) and studies advancing lens/catheter technologies and integration of nanotechnology and AI with plaque analytics. As one of the first papers from my collaboration with imaging bioengineers, Rob McLaughlin and Jiawen Li, it informed subsequent development of our new 3D-printed micro- and hybrid lenses, which gave rise to start-up, Vysena Medical, supported by $9M Cat 1 funding and valued at $24.5M.

 

Publication 8.

Citation: Carpenter HJ, Ghayesh MH, Zander AC, PSALTIS PJ*. “On the nonlinear relationship between wall shear stress topology and multi-directionality in coronary atherosclerosis.” COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2023; 231:107418. doi: 10.1016/j.cmpb.2023.107418

Explanation: Ground-breaking study using computational fluid dynamics and the more rigorous fluid-structure interaction technique to identify relationships between 12 new biomechanical metrics and coronary plaque, showing they are most critical in early-stage plaque development.

It opened a new biomechanical dimension to understanding plaque growth and instability, and informed studies in carotid and peripheral artery disease and aortic aneurysms. It led to a patent and creation of start-up, Corcillum Systems - founded by first author Carpenter, whom I mentored from PhD to industry leadership. Corcillum is valued at $20M and employs 7.6FTE staff, providing analytical software for studies at Mayo Clinic, UniSyd and UniQld, and firstin-human trials by NuevoSono Inc in North and South America.

 

Publication 9.

Citation: Dang QM, PSALTIS PJ*, Burgess S, Chandrasekhar J, Mukherjee S, Kritharides L,… Watts M, Marathe JA, Bhagwandeen R, Wing-Lun E, Bhindi R, Ford T, Lo S, Marschner S, Zaman S.

“The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.” EUROPEAN HEART JOURNAL. 2025; 46:2012-23. doi: 10.1093/eurheartj/ehaf097.ehaf097

Explanation: Reported the primary results of the ANZ-SCAD registry of 505 patients with spontaneous coronary artery dissection (SCAD). Key aspects included recruitment of Indigenous patients and the finding that dual antiplatelet use led to worse outcomes.

Editorialised by SCAD expert Tweet (Mayo Clinic, USA), cited by AUS and USA guidelines and widely disseminated on "X" to >500K followers, including by world leaders Gibson (USA) and Mamas (UK). It informed SCAD registries from Japan, EU and USA, the German-led SCAD-ALIGN trial comparing antiplatelet strategies and my new senior author paper in JAHA, which describes dysautonomia in SCAD for the first time.

 

Publication 10.

Citation: Kurugalage R, Bhatia A, Mukherjee A, Gunaseelan K, Figtree GA, Bursill CA, Dey D, Wong DTL, Marathe JA, PSALTIS PJ*. “Comparison of photon-counting and energy-integrating computed coronary tomography angiography for coronary artery disease: a systematic review and meta-analysis.” JACC CARDIOVASCULAR IMAGING 2026; Online ahead of print Jul 18. doi: 10.1016/j.jcmg.2026.05.021

Explanation: Meta-analysis of 15 studies (N=11,350) showing that advances in CT coronary angiography with photon-counting detector (PCD) technology result in down-classification of coronary stenosis severity compared to traditional energy integrating CT, with less downstream referrals for invasive angiography but greater yield of revascularisation when angiography is performed.

Largest and most rigorous meta-analysis of its kind, published in the top Cardiology imaging journal and praised by all 3 reviewers as “very relevant”, “timely”, “well-conducted”. Highlights key advantages of PCD-CT as the new gold standard for non-invasive plaque assessment, which is the basis for its use in my current proposal.

Date Position Institution name
2025 - ongoing Co-Deputy Director South Australian Health and Medical Research Institute
2024 - ongoing Level E Professor Adelaide University
2023 - 2025 Deputy Director South Australian Health and Medical Research Institute
2021 - ongoing Head, Interventional Cardiology, Department of Cardiology Royal Adelaide Hospital
2021 - ongoing Co-Lead, Lifelong Health Theme South Australian Health and Medical Research Institute
2021 - ongoing Program Lead, Heart and Vascular Health South Australian Health and Medical Research Institute
2016 - 2021 Deputy Leader, Heart and Vascular Health Program, Lifelong Health Theme South Australian Health and Medical Research Institute
2015 - 2018 Level C, Clinical Academic The University of Adelaide
2015 - ongoing Co-Director, Vascular Research Centre South Australian Health and Medical Research Institute
2015 - ongoing Consultant Cardiologist Adelaide Heart Clinic
2015 - ongoing Clinical Academic and Consultant Interventional Cardiologist Central Adelaide Local Health Network
2013 - 2014 Post-doctoral Research Fellow Monash University
2013 - 2014 Interventional Cardiology Fellow Monash Health
2010 - 2014 Post-doctoral Research Fellow University of Adelaide
2010 - 2012 Senior Research Fellow Mayo Clinic, Rochester
2009 - 2012 Post-doctoral Research/Senior Research Fellow Mayo Clinic
2004 - 2014 Senior Lecturer University of Adelaide

Date Type Title Institution Name Country Amount
2026 Award Professional Excellence Award Hellenic Australian Chamber of Commerce and Industry Australia -
2021 Award NHMRC Marshall and Warren Innovation Award, Most Innovative Ideas Grant for 2020 Round National Health and Medical Research Council Australia -
2021 Award Best Cover Paper Journal of Clinical Medicine Australia -
2016 Research Award Best Research Award, 5th International Congress on Lipid Metabolism and Atherosclerosis 5th International Congress on Lipid Metabolism and Atherosclerosis Korea, Republic of -
2013 Recognition Top Ten Abstract Gordon Research Conference - Atherosclerosis, Stowe United States -
2011 Award Early Career Investigator Award (Inaugural), American Heart Association Scientific Sessions Meeting, Orlando, FL, USA Arteriosclerosis Thrombosis and Vascular Biology Council United States -
2011 Award Best Poster Presentation Award, Mayo Research Fellows’ Association Mayo Clinic United States -
2011 Recognition Top Ten Abstract Gordon Research Conference - Atherosclerosis United States -
2009 Award The Ross Wishart Memorial Award for the Best Young Investigator Australian Society of Medical Research Australia -
2009 Award Best mini-oral Presentation - Runner-up Award, Australasian Section, 33rd Annual Scientific Meeting International Society for Heart Research Australia -
2009 Recognition Top 5% Abstract Ranking Cardiac Society of Australia and New Zealand Australia -
2009 Award Nimmo Prize, Best Oral Research Presentation Royal Adelaide Hospital Australia -
2008 Award Best Poster Prize, Research Expo The University of Adelaide Australia -
2007 Award Hugh Gilmore Prize, Best Oral Research Presentation Royal Adelaide Hospital Australia -
2006 Scholarship First ranked application, National Heart Foundation Post-Graduate Scholarship National Heart Foundation Australia -
2004 Teaching Award Outstanding Teaching and Service to Medical Students The University of Adelalaide Australia -
2004 Award Best Registrar Award, Selected by Interns Royal Adelaide Hospital Australia -
2003 Teaching Award Outstanding Teaching and Service to Medical Students The University of Adelaide Australia -

Language Competency
Greek, Modern (1453-) Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2023 European Society of Cardiology France Fellowship
2015 Cardiac Society of Australia and New Zealand Australia Fellowship
2010 University of Adelaide Australia Doctor of Philosophy
2006 Royal Australasian College of Physicians Australia Fellowship (Cardiology and Internal Medicine)
1999 University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery

Year Citation
2026 Lotfollahi, Z., Tan, J. T. M., Nankivell, V. A., Sandeman, L., Liyanage, S., Solly, E. L., . . . Bursill, C. A. (2026). Topical Reconstituted High-Density Lipoproteins Elicit Anti-Inflammatory Effects in Diabetic Wounds. Advances in Wound Care, 15(2), 91-106.
DOI Scopus4 WoS4 Europe PMC2
2026 Wattchow, N. E., Salagaras, T., Nguyen, M. T., Sandeman, L. Y. -J., Figtree, G. A., Di Giovanni, G., . . . Psaltis, P. J. (2026). Syndecan-1, Endocan and Non-Culprit Coronary Plaque Composition Following Non-St Elevation Myocardial Infarction. International Journal of Cardiology: Heart & Vasculature, 62, 8 pages.
DOI
2026 Di Giovanni, G., Fujino, M., Kataoka, Y., Butters, J., Hucko, T., Puri, R., . . . Nicholls, S. J. (2026). Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. European Journal of Preventive Cardiology, 33(11), 2047-2054.
DOI WoS7 Europe PMC7
2026 Psaltis, P. J., Nguyen, M. T., Liyanage, S., Salagaras, T., Sharma, S., Di Giovanni, G., . . . Nicholls, S. J. (2026). Persistent inflammation after myocardial infarction: elevated IL-6 associates with impaired coronary plaque stabilization despite optimal therapy. European Journal of Preventive Cardiology, 33(5), 794-797.
DOI Scopus2 WoS1 Europe PMC1
2026 Xie, C., White, J. B., Huang, W., Horowitz, M., Rayner, C. K., Verjans, J. W., . . . Wu, T. (2026). Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes. Diabetes, 75(4), 630-635.
DOI
2026 Chhay, P., Zhu, D., Tang, O., Gray, M. P., Vernon, S. T., Di Bartolo, B. A., . . . Figtree, G. A. (2026). Plasma fatty acid profiles and coronary artery disease burden assessed by coronary CT angiography: an observational study. Scientific Reports, 16(1), 10 pages.
DOI
2026 Ward, N. C., Watts, G. F., Bishop, W., Colquhoun, D., Hamilton-Craig, C., Hare, D. L., . . . Sullivan, D. R. (2026). Corrigendum to: “Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations” [Heart Lung Circ. 32(3) (2023) 287–296., (S1443950622012318), (10.1016/j.hlc.2022.11.015)]. Heart Lung and Circulation, 35(1), e15.
DOI
2026 Temple, F. T., Dang, Q., Burgess, S., Mukherjee, S., Chandrasekhar, J., Psaltis, P. J., . . . Zaman, S. (2026). Spontaneous Coronary Artery Dissection: Sex Differences in Clinical Presentation and Outcomes From the Australian New Zealand Registry. Journal of the American Heart Association, 15(5), 10 pages.
DOI Scopus2 WoS2 Europe PMC1
2026 Lim, M. Y., Nguyen, M. T., Winton, T., Psaltis, P. J., & Roberts-Thomson, R. (2026). Impact of Dedicated Cardiologist Input on the Rate of Prescription of Guideline-Directed Medical Therapy After Coronary Artery Bypass Graft Surgery—A Retrospective Cohort Study (The ROSS Effect). Heart Lung and Circulation, 35(4), e43-e46.
DOI
2026 Dang, Q. M., Zaheen, M., Pender, P., Chandrasekhar, J., Psaltis, P. J., Marathe, J. A., . . . Zaman, S. (2026). Health-Related Quality-of-Life and its Determinants After Acute Coronary Syndrome Caused by Spontaneous Coronary Artery Dissection.. Heart, lung & circulation, 35(4), 538-546.
DOI
2026 Fathieh, S., Gray, M. P., Kirkby, M., Genetzakis, E., Gholipour, A., Poole, C., . . . Grieve, S. M. (2026). Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease. Jacc Cardiovascular Imaging, 19(7), 857-880.
DOI Scopus2 WoS3
2026 Solly, E. L., Luo, Y., Primer, K. R., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., . . . Tan, J. T. M. (2026). Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound Healing. Diabetes, 75(6), 1024-1037.
DOI
2026 Bate, A. P., Franke, K. B., Nguyen, E., Sutton, D., Roberts-Thomson, R. L., Nelson, A. J., . . . Psaltis, P. J. (2026). Predictors of Adverse 30-Day Outcomes After Right Coronary Artery ST-Elevation Myocardial Infarction. Journal of Clinical Medicine, 15(7), 13 pages.
DOI
2026 Lotfollahi, Z., Solly, E. L., Tan, J. T. M., Nankivell, V. A., Sandeman, L., Stretton, L., . . . Bursill, C. A. (2026). The Functionality of High-Density Lipoproteins Is Impaired in People with Diabetes Who Require Minor Amputations. Advances in Wound Care, 1-19.
DOI
2026 Jung, H., S Haghighi, M., Dang, Q., Pender, P., Zaheen, M., Makarious, D., . . . Zaman, S. (2026). Ethnicity and its impact on presentation and outcomes in patients with spontaneous coronary artery dissection from the Australian-New Zealand registry. Heart, 8 pages.
DOI
2026 Grzeskowiak, L. E., Williams, L., Stark, M., Martinello, K. A., Keir, A., Ingman, W. V., . . . Amir, L. H. (2026). SUpporting Mothers Milk Intervention Trial (SUMMIT) - a randomised controlled trial comparing different doses of domperidone for treating lactation insufficiency in mothers of preterm infants - study protocol. International Breastfeeding Journal, 21(1), 1-48.
DOI
2026 Ju, Y., Tansu, N., Psaltis, P. J., & Ghayesh, M. H. (2026). Quantitative rapid image-based method for coronary artery blood flow and wall shear stress extraction. Frontiers in Bioengineering and Biotechnology, 14, 10 pages.
DOI
2026 Geremew, D., Tan, J. T. M., Psaltis, P. J., & Bursill, C. A. (2026). The asialoglycoprotein receptor 1 (ASGR1): emerging new roles in health and disease. Biomarker Research, 14(1), 98-1-98-19.
DOI
2026 Chan, N. S. L., Cross, C., Bowen, J., Prestidge, C., Ryan, F. J., Dorraki, M., . . . Joyce, P. (2026). The gut-heart axis in cardio-oncology. Cardiovascular Research (CVR), 122(12), 1573-1588.
DOI Scopus1 WoS1
2026 Kurugalage, R., Bhatia, A., Khan, N., Mukherjee, A., Marathe, J. A., & Psaltis, P. J. (2026). Diagnostic accuracy of photon-counting CT for in-stent restenosis: A preliminary meta-analysis. Journal of Cardiovascular Computed Tomography, S1934-5925(26)00409-0.
DOI
2026 O'brien, J. M., Ford, T. J., Yong, A., Goel, V., Spiro, J., Psaltis, P. J., . . . Wong, D. T. L. (2026). Coronary microvascular dysfunction: a narrative review. Cardiovascular Diagnosis and Therapy, 16(3), 19 pages.
DOI
2026 Salagaras, T., Nguyen, M. T., Liyanage, S., Sharma, S., Tan, J. T. M., Di Giovanni, G., . . . Psaltis, P. J. (2026). Cholesterol Efflux Capacity and Coronary Plaque Composition After Non-ST-Elevation Myocardial Infarction. Heart Lung and Circulation, 1-4.
DOI
2026 Kurugalage, R., Bhatia, A., Mukherjee, A., K, G., Figtree, G. A., Bursill, C. A., . . . Psaltis, P. J. (2026). Comparison of Photon-Counting and Energy-Integrating Computed Coronary Tomography Angiography for Coronary Artery Disease: A Systematic Review and Meta-Analysis. Jacc Cardiovascular Imaging, S1936-878X(26)00318-9.
DOI
2026 Nguyen, M. T., Marathe, J. A., & Psaltis, P. J. (2026). Residual risk in atherosclerotic cardiovascular disease A clinical overview. Medicine Today, 27(7), 10-20.
2026 Li, J., Tan, J. T. M., Xiang, L., Liu, J., Hoogendoorn, A., Nankivell, V. A., . . . Bursill, C. A. (2026). Serial Molecular-Microstructural Multimodal Intravascular Imaging of Atherosclerotic Plaques in Mice. Advanced Science, 1-11.
DOI
2026 Dang, Q. M., Zaheen, M., Pender, P., Chandrasekhar, J., Psaltis, P. J., Marathe, J. A., . . . Zaman, S. (2026). Quality of Care for Spontaneous Coronary Artery Dissection From the Australian–New Zealand SCAD Registry. Heart Lung and Circulation, S1443-9506(26)00225-8.
DOI
2026 Haghighi, M. S., Jung, H., Zaheen, M., Dang, Q. M., Pender, P., Chandrasekhar, J., . . . Marschner, S. (2026). Risks of Exogenous Sex Hormone Therapy Before and After Spontaneous Coronary Artery Dissection.. JACC. Advances, 103128.
DOI
2026 Ma, J. R., Tan, S., Watts, G. F., Lan, N. S. R., Hungerford, R., Psaltis, P. J., . . . Nelson, A. J. (2026). Interpreting Triglycerides: A National Cross-Sectional Review of Laboratory Reporting Practices. Diabetes Obesity and Metabolism, 4 pages.
DOI
2026 Chen, Y., To, M. -S., Carpenter, H. J., Psaltis, P. J., & Li, J. (2026). Deep learning for intravascular optical coherence tomography: a review of plaque analysis. Artificial Intelligence Review, 59(10), 211-1-211-41.
DOI
2026 Kushwaha, A. K., Marathe, J. A., Finnie, J. W., Tan, J. T. M., Manavis, J., Xiang, L., . . . Li, J. (2026). Progressive coronary atherosclerosis in a porcine model of diabetes: a pilot study. Scientific Reports, 1-14.
DOI
2026 O'Brien, J. M., Zhang, M., Ford, T. J., Psaltis, P. J., Marathe, J. A., Ravindran, J., . . . Wong, D. T. L. (2026). Diagnostic Accuracy and Feasibility of Quantitative Flow Ratio at Low Frame Rate Angiography: The Prospective Multicentre Australian AVALON Study. Catheterization and Cardiovascular Interventions, 9 pages.
DOI
2025 Psaltis, J. P., Marathe, J. A., Nguyen, M. T., Le, R., Bursill, C. A., Marathe, C. S., . . . Psaltis, P. J. (2025). Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future. Medicinal Research Reviews, 45(1), 29-65.
DOI Scopus38 WoS33 Europe PMC31
2025 Psaltis, P. J., Nguyen, M. T., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., . . . Nicholls, S. J. (2025). Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research, 121(3), 468-478.
DOI Scopus40 WoS40 Europe PMC37
2025 Evans, S., Howson, S. A., Booth, A. E. C., Shahmohamadi, E., Lim, M., Bacchi, S., . . . Sanders, P. (2025). Artificial intelligence age prediction using electrocardiogram data: Exploring biological age differences. Heart Rhythm, 22(6), 1492-1497.
DOI Scopus6 WoS6 Europe PMC5
2025 Misra, A., Psaltis, P. J., Mondal, A. R., Nelson, A. J., & Nidorf, S. M. (2025). Implications and limitations of the CLEAR-SYNERGY trial for the use of low-dose colchicine in cardiovascular disease. Nature Cardiovascular Research, 4(3), 3 pages.
DOI Scopus17 WoS16 Europe PMC13
2025 Thurston, B., Satheakeerthy, S., Hains, L., Booth, A. E. C., Gao, C., Bellinge, J., . . . Bacchi, S. (2025). Computer-Assisted Protocol-Adherent Blood Lipid Evaluation in Vascular Outpatients (CAPABLE-Vascular). Journal of Clinical Medicine, 14(4), 1321.
DOI
2025 Dang, Q. M., Psaltis, P. J., Burgess, S., Chandrasekhar, J., Mukherjee, S., Kritharides, L., . . . Zaman, S. (2025). The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.. Eur Heart J, 46(21), 2012-2023.
DOI Scopus41 WoS38 Europe PMC28
2025 Fujino, M., Di Giovanni, G., Butters Bhsc, J., Kataoka, Y., Hucko, T., Nelson, A. J., . . . Nicholls, S. J. (2025). Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS. Atherosclerosis, 403, 119145.
DOI Scopus10 WoS9 Europe PMC6
2025 Ruchka, P., Kushwaha, A., Marathe, J. A., Xiang, L., Chen, R., Kirk, R., . . . Li, J. (2025). 3D-printed micro-axicon enables extended depth-of-focus intravascular optical coherence tomography in vivo. Advanced Photonics, 7(2), 026003-1-026003-10.
DOI Scopus24 WoS22
2025 Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V. A., Stretton, L. G., Solly, E. L., . . . Bursill, C. A. (2025). Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia.. Arterioscler Thromb Vasc Biol, 45(5), 683-701.
DOI Scopus4 WoS4 Europe PMC2
2025 Wattchow, N. E., Pullen, B. J., Indraratna, A. D., Nankivell, V., Everest-Dass, A., Psaltis, P. J., . . . Bursill, C. A. (2025). The emerging role of glycans and the importance of sialylation in cardiovascular disease. Atherosclerosis, 403, 119172-1-119172-11.
DOI Scopus5 WoS5 Europe PMC5
2025 Chen, R., Rothermel, F., Fitridge, R., Bursill, C. A., Psaltis, P. J., Giessen, H., . . . Li, J. (2025). Low background fluorescence 3D-printed micro-lens for imaging of vulnerable atherosclerotic plaques. APL Photonics, 10(4), 040805-1-040805-10.
DOI Scopus7 WoS7
2025 Freidoonimehr, N., Atkins, T., Marathe, J. A., Psaltis, P. J., & Arjomandi, M. (2025). Evaluating the severity of tandem coronary stenoses: Insights from simulated FFR and iFR techniques.. J Biomech, 185, 112707.
DOI Scopus4 WoS4 Europe PMC2
2025 Bate, A. P., Psaltis, P. J., Nicholls, S. J., & Nelson, A. J. (2025). Upfront Combination Therapy for LDL-C Lowering in Acute Coronary Syndrome: The Rule Rather than the Exception?. Heart Lung and Circulation, 34(5), 409-411.
DOI
2025 Ford, T., Zeitz, C., Spiro, J., Yong, A., Layland, J., Watts, M., . . . Beltrame, J. F. (2025). Functional Coronary Angiography for the Diagnosis of Coronary Vasomotor Disorders. Heart Lung and Circulation, 34(9), e89-e103.
DOI Scopus2 WoS2 Europe PMC1
2025 Fathieh, S., Tang, O., Gray, M. P., Zanchin, C., Vernon, S. T., Genetzakis, E., . . . Figtree, G. A. (2025). Evaluating the Role of Lipoprotein(a) in Enhancing Risk Stratification for the Presence and Extent of Subclinical Coronary Artery Disease Burden - A BioHEART-CT Study. European Journal of Preventive Cardiology, 1-11.
DOI WoS13 Europe PMC8
2025 Nguyen, M. T., Nelson, A. J., & Psaltis, P. J. (2025). Colchicine in Atherosclerotic Cardiovascular Disease - Weighing up the evidence so far.. Eur J Prev Cardiol, 33(5), 705-706.
DOI Scopus2 WoS2 Europe PMC2
2025 White, J. B., Lin, A., Montarello, N. J., Bursill, C. A., Figtree, G. A., Dey, D., . . . Psaltis, P. J. (2025). Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction. Atherosclerosis, 408, 120421-1-120421-9.
DOI Scopus1 WoS2 Europe PMC1
2025 Rao, S. R., Salagaras, T., Chen, Y. -C., Bursill, C. A., Peter, K., Snel, M. F., & Psaltis, P. J. (2025). Proteomic Effects of Colchicine on Human Macrophages Loaded With Oxidised Low-Density Lipoprotein Cholesterol.. Heart Lung and Circulation, 34(9), 980-983.
DOI Scopus1 WoS1 Europe PMC1
2025 Nankivell, V. A., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2025). Theranostic porphyrin nanoparticles identify atherosclerosis via multimodal imaging and elicit atheroprotective effects. Materials Today Bio, 34, 102202.
DOI Scopus6 WoS5 Europe PMC2
2025 Lim, M. Y., Allahwala, M. A., Booth, A. E. C., Evans, S., Jesudason, D., Marathe, J. A., . . . Nelson, A. J. (2025). Prevalence of Overweight and Obesity Among Patients Admitted With Acute Coronary Syndromes: Implications for Semaglutide Eligibility to Further Reduce Residual Risk.. Heart, lung & circulation, 34(10), S1443-9506(25)01556-2.
DOI Scopus1
2025 Allahwala, M. A., Marathe, C. S., Nelson, A. J., Psaltis, P. J., & Marathe, J. A. (2025). Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond. Heart Lung and Circulation, 34(10), 995-1005.
DOI Scopus12 WoS9 Europe PMC5
2025 Sivakumar, S., Cheng, K., Lin, A., Psaltis, P. J., Figtree, G., & Wong, D. T. L. (2025). Coronary Inflammation in Patients With and Without Standard Modifiable Cardiovascular Risk Factors: Insights From a Novel Computed Tomography Imaging Biomarker Pericoronary Adipose Tissue Attenuation.. Heart, lung & circulation, 34(10), S1443-9506(25)01568-9.
DOI Scopus1 WoS1
2025 Allahwala, M. A., Booth, A. E. C., Nelson, A. J., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2025). Type 2 Diabetes and Acute Myocardial Infarction: Admission Complexity and Readmission Rates.. Heart Lung Circ, 34(10), e145-e148.
DOI Scopus2 WoS1
2025 Lan, N. S. R., Psaltis, P. J., Alicic, R., & Arnott, C. (2025). Cardiovascular-Kidney-Metabolic Syndrome: Rethinking Risk, Redefining Care. Heart Lung and Circulation, 34(10), 987-990.
DOI
2025 Chhay, P., Tang, O., Ai, L., Cordwell, S. J., Gray, M. P., Yang, J. Y., . . . Figtree, G. A. (2025). Digging Deeper Into Cardiovascular Plasma Proteomics: Opportunities and Limitations of Current Platforms. Circulation. Genomic and precision medicine, 18(5), 583-601.
DOI Scopus5 WoS4 Europe PMC1
2025 Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a Novel Murine Model of In-Stent Neoatherosclerosis. Journal of the American Heart Association, 14(22), e041260-1-e041260-16.
DOI Scopus2 WoS3 Europe PMC2
2025 Lim, M. Y., Macleod, K., Kumar, K., Jeffries, A., Floridis, J., Ellis, D. Y., . . . Marathe, J. A. (2025). Thrombolysis of Acute ST-Segment Elevation Myocardial Infarction With Concurrent Polytrauma. Jacc Case Reports, 30(37), 105734.
DOI
2025 Brieger, D. G., Nelson, A. J., Figtree, G. A., & Psaltis, P. J. (2025). Real-World Uptake of Intravascular Imaging for Percutaneous Coronary Intervention: From Exception to Everyday Practice. Heart Lung and Circulation, 34(11), 1144-1146.
DOI
2025 Hamilton-Craig, I. R., Psaltis, P. J., Marston, N. A., & Nelson, A. J. (2025). Letter to the Editor: “No Time to Waste - Upfront Combination Lipid Lowering Therapy for Post-Acute Coronary Syndromes,” Regarding the: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025 by Brieger et al., Heart Lung Circ. 2025;34:309–397.. Heart Lung and Circulation, 34(12), e172-e173.
DOI
2025 Allahwala, M. A., Wattchow, N., Dwyer, A., Wong, D. T. L., Bursill, C., Marathe, J. A., & Psaltis, P. J. (2025). Unappreciated Coronary Artery Ectasia Leading to Stent Failure.. JACC Case Rep, 31(5), 106313.
DOI
2024 Dorraki, M., Liao, Z., Abbott, D., Psaltis, P., Baker, E., Bidargaddi, N., . . . Verjans, J. (2024). Improving Cardiovascular Disease Prediction With Machine Learning Using Mental Health Data: A Prospective UK Biobank Study. JACC: Advances, 3(9), 101180-1-101180-9.
DOI
2024 Bate, A. P., Franke, K. B., Jones, D. R., Chokka, R. G., Gibb, C., Lau, J. K., . . . Roberts-Thomson, R. L. (2024). Psoas Muscle Area as a Predictor of Transcatheter Aortic Valve Implantation Outcomes.. Heart Lung Circ, 33(3), 310-315.
DOI Scopus7 WoS7 Europe PMC6
2024 Zaka, A., Mutahar, D., Ponen, K., Abtahi, J., Mridha, N., Williams, A. B., . . . Bhamidipaty, V. (2024). Prognostic value of left ventricular systolic function before vascular surgery: a systematic review.. ANZ J Surg, 94(5), 826-832.
DOI
2024 Wong, N. K. P., Solly, E. L., Le, R., Nankivell, V. A., Mulangala, J., Psaltis, P. J., . . . Tan, J. T. M. (2024). TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. International Journal of Molecular Sciences, 25(6), 3343.
DOI Scopus5 WoS5 Europe PMC4
2024 Nankivell, V., Vidanapathirana, A. K., Hoogendoorn, A., Tan, J. T. M., Verjans, J., Psaltis, P. J., . . . Bursill, C. A. (2024). Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. Cardiovascular Research, 120(8), 819-838.
DOI Scopus36 WoS33 Europe PMC32
2024 Franke, K. B., Montarello, N. J., Nelson, A. J., Marathe, J. A., Wong, D. T. L., Tavella, R., . . . Psaltis, P. J. (2024). Tandem lesions associate with angiographic progression of coronary artery stenoses. International Journal of Cardiology: Heart & Vasculature, 52, 101417-1-101417-8.
DOI Scopus5 WoS4
2024 Mahadevan, J. J., Psaltis, P. J., Thrift, A. G., & Kleinig, T. J. (2024). Incidence of thrombocytopenia-associated cerebral venous sinus thrombosis: a population-based study. BMJ Neurology Open, 6(1), e000605-1-e000605-3.
DOI Scopus1 WoS2 Europe PMC1
2024 Chen, R., Sandeman, L., Nankivell, V., Tan, J. T. M., Rashidi, M., Psaltis, P. J., . . . Li, J. (2024). Detection of atherosclerotic plaques with HDL-like porphyrin nanoparticles using an intravascular dual-modality optical coherence tomography and fluorescence system. Scientific Reports, 14(1), 12359-1-12359-10.
DOI Scopus14 WoS11 Europe PMC8
2024 Agbaedeng, T. A., Noubiap, J. J., Roberts, K. A., Chew, D. P., Psaltis, P. J., & Amare, A. T. (2024). Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis. Drugs, 84(6), 685-701.
DOI Scopus6 WoS7 Europe PMC5
2024 Stretton, B., Booth, A. E. C., Satheakeerthy, S., Howson, S., Evans, S., Kovoor, J., . . . Bacchi, S. (2024). Translational artificial intelligence-led optimization and realization of estimated discharge with a supportive weekend interprofessional flow team (TAILORED-SWIFT). Internal and Emergency Medicine, 19(7), 1913-1919.
DOI Scopus5 WoS4 Europe PMC7
2024 Moore, E., Robson, A. J., Crisp, A. R., Cockshell, M. P., Burzava, A. L. S., Ganesan, R., . . . Bonder, C. S. (2024). Study of the Structure of Hyperbranched Polyglycerol Coatings and their Anti-Biofouling and Anti-Thrombotic Applications. Advanced Healthcare Materials, 13(26), 2401545-1-2401545-23.
DOI Scopus6 WoS5 Europe PMC5
2024 Cheng, K., Lin, A., Psaltis, P. J., Rajwani, A., Baumann, A., Brett, N., . . . Wong, D. T. L. (2024). Protocol and rationale of the Australian multicentre registry for serial cardiac computed tomography angiography (ARISTOCRAT): a prospective observational study of the natural history of pericoronary adipose tissue attenuation and radiomics. Cardiovascular Diagnosis & Therapy, 14(3), 447-458.
DOI Scopus2 WoS2 Europe PMC1
2024 Kamalanathan, H., Hains, L., Bacchi, S., Martin, W. N., Zaka, A., Slattery, F., . . . Kovoor, P. (2024). Listen to your heart: a critical analysis of popular cardiology podcasts. Frontiers in Medicine, 11, 1278449.
DOI
2024 Williamson, A. E., Liyanage, S., Hassanshahi, M., Dona, M. S. I., Toledo-Flores, D., Tran, D. X. A., . . . Psaltis, P. J. (2024). Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nature Communications, 15(1), 7097-1-7097-21.
DOI Scopus16 WoS17 Europe PMC14
2024 Le, R., Nguyen, M. T., Allahwala, M. A., Psaltis, J. P., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2024). Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs. Journal of Clinical Medicine, 13(16), 31 pages.
DOI Scopus57 WoS50 Europe PMC38
2024 Satheakeerthy, S., Stretton, B., Booth, A. E. C., Howson, S., Evans, S., Kovoor, J., . . . Bacchi, S. (2024). Push or pull? Digital notification platform implementation reduces dysglycaemia.. Internal Medicine Journal, 54(10), 1753-1756.
DOI Scopus4 WoS4 Europe PMC4
2024 Baumann, A. A. W., Roberts-Thomson, R. L., Shah, R., Reynolds, G. F., Marangou, J., Tayeb, H., . . . Ilton, M. (2024). Prevalence and burden of coronary artery disease on computed tomography coronary angiography and its correlation with high-density lipoprotein in the Northern Territory, Australia. Cardiovascular Diagnosis and Therapy, 14(4), 725-730.
DOI Scopus1 WoS1 Europe PMC1
2024 Boord, M. S., Feuerriegel, D., Coussens, S. W., Davis, D. H. J., Psaltis, P. J., Garrido, M. I., . . . Keage, H. A. D. (2024). Neurophysiological patterns reflecting vulnerability to delirium subtypes: A resting-state EEG and event-related potential study. Brain Communications, 6(5), fcae298-1-fcae298-13.
DOI Scopus6 WoS5 Europe PMC7
2024 Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., . . . Verjans, J. W. (2024). Improving Cardiovascular Disease Prediction With Machine Learning Using Mental Health Data: A Prospective UK Biobank Study. JACC: Advances, 3(9.2), 101180-1-101180-9.
DOI Scopus23 WoS11 Europe PMC10
2024 Ekmejian, A. A., Carpenter, H. J., Ciofani, J. L., Gray, B. H. M., Allahwala, U. K., Ward, M., . . . Bhindi, R. (2024). Advances in the Computational Assessment of Disturbed Coronary Flow and Wall Shear Stress: A Contemporary Review. Journal of the American Heart Association, 13(19), 13 pages.
DOI Scopus27 WoS22 Europe PMC11
2024 Nguyen, M. T., Lambrakis, K., Lehman, S., Haustead, D., Psaltis, P. J., Chew, D. P., & Papendick, C. (2024). High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use. JAMA network open, 7(10), e2438541.
DOI Scopus4 WoS4 Europe PMC4
2024 Wang, X., Ghayesh, M. H., Li, J., Kotousov, A., Zander, A. C., Dawson, J. A., & Psaltis, P. J. (2024). Impact of Geometric Attributes on Abdominal Aortic Aneurysm Rupture Risk: An In Vivo FSI-Based Study. International Journal for Numerical Methods in Biomedical Engineering, 40(12), e3884-1-e3884-21.
DOI Scopus7 WoS5 Europe PMC2
2024 Misra, A., Psaltis, P. J., & Nidorf, S. M. (2024). Editorial: Role of colchicine in atherosclerosis. Frontiers in Cardiovascular Medicine, 11, 1516185.
DOI Scopus2 WoS1 Europe PMC1
2024 Dang, Q., Burgess, S., Psaltis, P. J., Fairley, S., Saw, J., & Zaman, S. (2024). Spontaneous coronary artery dissection: a clinically oriented narrative review. Npj Cardiovascular Health, 1(1), 4.
DOI Scopus23 Europe PMC8
2023 Nicholls, S. J., Kataoka, Y., Nissen, S. E., Prati, F., Windecker, S., Puri, R., . . . Psaltis, P. J. (2023). Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. JACC: Cardiovascular Imaging, 16(1), 130-132.
DOI Scopus8 WoS8 Europe PMC5
2023 Ihdayhid, A. R., Lan, N. S. R., Figtree, G. A., Patel, S., Arnott, C., Hamilton-Craig, C., . . . Nicholls, S. J. (2023). Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT.. Heart, lung & circulation, 32(3), S1443-9506(22)01235-5.
DOI Scopus11 WoS11 Europe PMC12
2023 Ward, N. C., Watts, G. F., Bishop, W., Colquhoun, D., Hamilton-Craig, C., Hare, D. L., . . . Sullivan, D. R. (2023). Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations.. Heart Lung Circ, 32(3), 287-296.
DOI Scopus27 WoS23 Europe PMC20
2023 Franke, K. B., Bhatia, D., Roberts-Thomson, R. L., & Psaltis, P. J. (2023). Aortic valve replacement reduces mortality in moderate aortic stenosis: a systematic review and meta-analysis. JOURNAL OF GERIATRIC CARDIOLOGY, 20(1), 61-67.
DOI Scopus7 WoS6 Europe PMC7
2023 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2023). On the nonlinear relationship between wall shear stress topology and multi-directionality in coronary atherosclerosis. Computer Methods and Programs in Biomedicine, 231, 107418-1-107418-26.
DOI Scopus29 WoS26 Europe PMC20
2023 Montarello, N., Leslie, A., Chhetri, R., Friel, O., Singhal, D., Ross, D. M., . . . Hiwase, D. K. (2023). Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes.. Blood Advances, 7(13), 3032-3035.
DOI Scopus2 WoS2 Europe PMC2
2023 Schwarz, N., Fernando, S., Chen, Y. -C., Salagaras, T., Rao, S. R., Liyanage, S., . . . Psaltis, P. J. (2023). Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. The FASEB Journal, 37(4), 1-20.
DOI Scopus76 WoS71 Europe PMC64
2023 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2023). Effect of coronary artery dynamics on the wall shear stress vector field topological skeleton in fluid-structure interaction analyses. International Journal of Mechanical System Dynamics, 3(1), 48-57.
DOI Scopus15 WoS12
2023 Greaves, D., Astley, J., Psaltis, P. J., Lampit, A., Davis, D. H. J., Ghezzi, E. S., . . . Keage, H. A. D. (2023). The effects of computerised cognitive training on post-CABG delirium and cognitive change: a prospective randomised controlled trial. Delirium, online, 1-12.
DOI Europe PMC9
2023 Nguyen, M. T., Ali, A., Ngo, L., Ellis, C., Psaltis, P. J., & Ranasinghe, I. (2023). Thirty-Day Unplanned Readmissions Following Elective and Acute Percutaneous Coronary Intervention. Heart Lung and Circulation, 32(5), 619-628.
DOI Scopus2 WoS1 Europe PMC1
2023 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., Dawson, J. A., & Psaltis, P. J. (2023). Fluid-structure interaction study for biomechanics and risk factors in Stanford type A aortic dissection.. Int J Numer Method Biomed Eng, 39(8), 25 pages.
DOI Scopus19 WoS15 Europe PMC13
2023 Wang, X., Carpenter, H. J., Ghayesh, M. H., Kotousov, A., Zander, A. C., Amabili, M., & Psaltis, P. J. (2023). A review on the biomechanical behaviour of the aorta. Journal of the Mechanical Behavior of Biomedical Materials, 144, 1-38.
DOI Scopus48 WoS44 Europe PMC30
2023 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., & Psaltis, P. J. (2023). Failure investigation and stresses in abdominal aortic aneurysms fluid-structure interaction biomechanics: Effect of nonlinear material properties and presence of intraluminal thrombus. Procedia Structural Integrity, 45, 88-95.
DOI Scopus3
2023 Ghezzi, E. S., Sharman, R. L. S., Selvanayagam, J. B., Psaltis, P. J., Sanders, P., Astley, J. M., . . . Keage, H. A. D. (2023). Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(6), 1-15.
DOI Scopus61 WoS54 Europe PMC39
2023 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., Amabili, M., Dawson, J. A., & Psaltis, P. J. (2023). Biomechanics of abdominal aortic aneurysm in the framework of Windkessel effect and fully-developed inflow velocity via two-way non-linear FSI. International Journal of Non-Linear Mechanics, 157, 104517.
DOI Scopus14 WoS13
2023 Figtree, G. A., Vernon, S. T., Harmer, J. A., Gray, M. P., Arnott, C., Bachour, E., . . . Zwack, C. (2023). Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 82(13), 1343-1359.
DOI Scopus86 WoS98 Europe PMC89
2023 Kott, K. A., Chan, A. S., Vernon, S. T., Hansen, T., Kim, T., de Dreu, M., . . . Figtree, G. A. (2023). Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease. Clinical and Translational Immunology, 12(11), e1462-1-e1462-18.
DOI Scopus9 WoS8 Europe PMC8
2023 Dang, Q., Othman, F., Sheahen, B., Marschner, S., Psaltis, P., Al-Lamee, R. K., . . . Zaman, S. (2023). Regional and temporal variations of spontaneous coronary artery dissection care according to consensus recommendations: a systematic review and meta-analysis. Open Heart, 10(2), e002379-1-e002379-12.
DOI Scopus9 WoS5 Europe PMC5
2022 Montarello, N. J., Nguyen, M. T., Wong, D. T. L., Nicholls, S. J., & Psaltis, P. J. (2022). Inflammation in coronary atherosclerosis and its therapeutic implications. Cardiovascular Drugs and Therapy, 36(2), 347-362.
DOI Scopus60 WoS58 Europe PMC44
2022 Parvar, S. L., Ngo, L., Dawson, J., Nicholls, S. J., Fitridge, R., Psaltis, P. J., & Ranasinghe, I. (2022). Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis. European Heart Journal, 43(1), 32-40.
DOI Scopus28 WoS23 Europe PMC21
2022 Li, J., Montarello, N., Hoogendoorn, A., Verjans, J., Bursill, C., Peter, K., . . . Psaltis, P. (2022). Multimodality intravascular imaging of high-risk coronary plaque. JACC: Cardiovascular Imaging, 15(1), 145-159.
DOI Scopus66 WoS64 Europe PMC53
2022 Montarello, N. J., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., Rajendran, S., . . . Psaltis, P. J. (2022). Assessing the impact of colchicine on coronary plaque phenotype after myocardial infarction with optical coherence tomography: rationale and design of the COCOMO-ACS study. Cardiovascular Drugs and Therapy, 36(6), 1175-1186.
DOI Scopus24 WoS24 Europe PMC19
2022 Fernando, S., Salagaras, T., Schwarz, N., Sandeman, L., Tan, J. T. M., Xie, J., . . . Psaltis, P. J. (2022). Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. The FASEB Journal, 36(2), 1-19.
DOI Scopus6 WoS7 Europe PMC6
2022 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., Ottaway, J. L., Di Giovanni, G., Nicholls, S. J., & Psaltis, P. J. (2022). Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression. Jove-Journal of Visualized Experiments, 2022(179), e62933-1-e62933-35.
DOI Scopus5 WoS5 Europe PMC2
2022 White, J. B., Trim, P. J., Salagaras, T., Long, A., Psaltis, P. J., Verjans, J. W., & Snel, M. F. (2022). Equivalent Carbon Number and Interclass Retention Time Conversion Enhance Lipid Identification in Untargeted Clinical Lipidomics. Analytical Chemistry, 94(8), 3476-3484.
DOI Scopus30 WoS30 Europe PMC23
2022 Li, J., Thiele, S., Kirk, R. W., Quirk, B. C., Hoogendoorn, A., Chen, Y. C., . . . McLaughlin, R. A. (2022). 3D-printed micro lens-in-lens for in vivo multimodal microendoscopy. Small, 18(17), 2107032-1-2107032-8.
DOI Scopus84 WoS77 Europe PMC37
2022 Baumann, A. A. W., Tavella, R., Air, T. M., Mishra, A., Montarello, N. J., Arstall, M., . . . Psaltis, P. J. (2022). Prevalence and real-world management of NSTEMI with multivessel disease. Cardiovascular Diagnosis and Therapy, 12(1), 1-11.
DOI Scopus29 WoS28 Europe PMC20
2022 Nidorf, S. M., Layland, J., Robinson, P. C., Patel, S., Psaltis, P. J., & Thompson, P. L. (2022). Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease. The Medical Journal of Australia, 216(8), 1-3.
DOI Scopus1 WoS2 Europe PMC2
2022 Nicholls, S. J., Kataoka, Y., Nissen, S. E., Prati, F., Windecker, S., Puri, R., . . . Psaltis, P. J. (2022). Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. JACC: Cardiovascular Imaging, 15(7), 1308-1321.
DOI Scopus447 WoS416 Europe PMC368
2022 Patel, A., Ngo, L., Woodman, R. J., Aliprandi-Costa, B., Bennetts, J., Psaltis, P. J., & Ranasinghe, I. (2022). Institutional variation in early mortality following isolated coronary artery bypass graft surgery.. International journal of cardiology, 362, 35-41.
DOI Scopus5 Europe PMC3
2022 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., Li, J., Di Giovanni, G., & Psaltis, P. J. (2022). Automated Coronary Optical Coherence Tomography Feature Extraction with Application to Three-Dimensional Reconstruction. Tomography, 8(3), 1307-1349.
DOI Scopus19 WoS16 Europe PMC12
2022 Figtree, G. A., Vernon, S. T., Hadziosmanovic, N., Sundström, J., Alfredsson, J., Nicholls, S. J., . . . Hagström, E. (2022). Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.. Journal of the American Heart Association, 11(15), 1-33.
DOI Scopus50 WoS49 Europe PMC45
2022 Vidanapathirana, A. K., Goyne, J. M., Williamson, A. E., Pullen, B. J., Chhay, P., Sandeman, L., . . . Bursill, C. A. (2022). Biological Sensing of Nitric Oxide in Macrophages and Atherosclerosis Using a Ruthenium-Based Sensor. Biomedicines, 10(8), 1807.
DOI Scopus10 WoS9 Europe PMC7
2022 Baumann, A. A., Roberts-Thomson, R. L., & Psaltis, P. J. (2022). CT or Invasive Coronary Angiography in Stable Chest Pain. The New England journal of medicine, 387(4), 377-378.
DOI WoS10
2022 Kim, S. K., Wing-Lun, E., Chandrasekhar, J., Puri, A., Burgess, S., Ford, T. J., . . . Zaman, S. (2022). The Australian New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry – A Multi-Centre Cohort Study: Protocol, Background and Significance. Heart Lung and Circulation, 31(12), 1612-1618.
DOI Scopus13 WoS10 Europe PMC10
2022 Figtree, G. A., Adamson, P. D., Antoniades, C., Blumenthal, R. S., Blaha, M., Budoff, M., . . . Nicholls, S. J. (2022). Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development. Circulation, 146(22), 1712-1727.
DOI Scopus35 WoS32 Europe PMC28
2021 Franke, K. B., Nerlekar, N., Marshall, H., & Psaltis, P. J. (2021). Systematic review and meta-Analysis of the clinical characteristics and outcomes of spontanous coronary artery dissection. International Journal of Cardiology, 322, 34-39.
DOI Scopus32 WoS28 Europe PMC24
2021 Vidanapathirana, A. K., Psaltis, P. J., Bursill, C. A., Abell, A. D., & Nicholls, S. J. (2021). Cardiovascular bioimaging of nitric oxide: achievements, challenges, and the future. Medicinal research reviews, 41(1), 435-463.
DOI Scopus40 WoS34 Europe PMC29
2021 Boord, M. S., Moezzi, B., Davis, D., Ross, T. J., Coussens, S., Psaltis, P. J., . . . Keage, H. A. D. (2021). Investigating how electroencephalogram measures associate with delirium: a systematic review. Clinical Neurophysiology, 132(1), 246-257.
DOI Scopus68 WoS67 Europe PMC58
2021 Opperman, K. S., Vandyke, K., Psaltis, P. J., Noll, J. E., & Zannettino, A. C. W. (2021). Macrophages in multiple myeloma: key roles and therapeutic strategies. Cancer and Metastasis Reviews, 40(1), 273-284.
DOI Scopus26 WoS24 Europe PMC24
2021 Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . Pang, J. (2021). Synopsis of an Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia: an Australian Perspective. American Journal of Preventive Cardiology, 6, 100151-1-100151-9.
DOI Scopus8 WoS8 Europe PMC5
2021 Nicholls, S. J., Nissen, S. E., Prati, F., Windecker, S., Kataoka, Y., Puri, R., . . . Psaltis, P. J. (2021). Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. Cardiovascular Diagnosis and Therapy, 11(1), 120-129.
DOI Scopus69 WoS61 Europe PMC55
2021 Morrison, K. R., Solly, E. L., Shemesh, T., Psaltis, P. J., Nicholls, S. J., Brown, A., . . . Tan, J. T. M. (2021). Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people. Diabetologia, 64(6), 1402-1411.
DOI Scopus22 WoS23 Europe PMC20
2021 Carpenter, H., Gholipour, A., Ghayesh, M., Zander, A. C., & Psaltis, P. (2021). In vivo based fluid-structure interaction biomechanics of the left anterior descending coronary artery. Journal of Biomechanical Engineering, 143(8), 081001-1-081001-18.
DOI Scopus17 WoS16 Europe PMC8
2021 Pisaniello, A. D., Psaltis, P. J., King, P. M., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Di Bartolo, B. A. (2021). Omega-3 fatty acids ameliorate vascular inflammation: a rationale for their atheroprotective effects. Atherosclerosis, 324, 27-37.
DOI Scopus46 WoS43 Europe PMC44
2021 Roberts-Thomson, R. L., Baumann, A., Reade, J., Culgan, L., Kaethner, A., Ilton, M., . . . Brown, A. (2021). Surgical and percutaneous management of Aboriginal Australians with rheumatic heart disease: timeliness and concordance between practice and guidelines. International Journal of Cardiology, 335, 80-84.
DOI Scopus4 WoS4 Europe PMC3
2021 Nankivell, V. A., Tan, J. T. M., Wilsdon, L. A., Morrison, K. R., Bilu, C., Psaltis, P. J., . . . Brown, A. (2021). Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus. Scientific reports, 11(1), 1-13.
DOI Scopus15 WoS14 Europe PMC13
2021 Yuvaraj, J., Cheng, K., Lin, A., Psaltis, P. J., Nicholls, S. J., & Wong, D. T. L. (2021). The Emerging Role of CT-Based Imaging in Adipose Tissue and Coronary Inflammation. Cells, 10(5), 18 pages.
DOI Scopus34 WoS33 Europe PMC31
2021 Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . Psaltis, P. (2021). Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians.. Intern Med J, 51(5), 769-779.
DOI Scopus8 WoS7 Europe PMC6
2021 Zalewski, P. D., Tvorogova, Z., Abdo, A., Wawer, A. A., Hodge, S., Murgia, C., . . . Beltrame, J. F. (2021). Harvesting endothelial cells during routine invasive coronary procedures. Journal of the American College of Cardiology, 77(24), 3136-3138.
DOI Scopus2 WoS2 Europe PMC1
2021 Ghezzi, E. S., Psaltis, P. J., Loetscher, T., Davis, D., Montarello, J., Lau, J. K., . . . Keage, H. A. D. (2021). Identifying New Factors Associated With Cognitive Decline and Delirium After Transcatheter Aortic Valve Implantation: A Study Protocol. FRONTIERS IN CARDIOVASCULAR MEDICINE, 8(657057), 11 pages.
DOI Scopus3 WoS2 Europe PMC2
2021 Solly, E. L., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2021). The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications. Frontiers in Pharmacology, 12, 718679-1-718679-16.
DOI Scopus21 WoS20 Europe PMC18
2021 Besnier, M., Finemore, M., Yu, C., Kott, K. A., Vernon, S. T., Seebacher, N. A., . . . Figtree, G. A. (2021). Patient endothelial colony-forming cells to model coronary artery disease susceptibility and unravel the role of dysregulated mitochondrial redox signalling. Antioxidants, 10(10), 1-17.
DOI Scopus16 WoS15 Europe PMC16
2021 Davies, A., Roberts-Thompson, R., Puri, R., & Psaltis, P. (2021). Position Statements for Transcatheter Valve Therapies in Australia: Accreditation Standards and Heart Team Opportunities. Heart Lung and Circulation, 30(12), 1787-1789.
DOI Scopus3 WoS3 Europe PMC3
2021 Boord, M. S., Davis, D. H. J., Psaltis, P. J., Coussens, S. W., Feuerriegel, D., Garrido, M. I., . . . Keage, H. A. D. (2021). DelIrium VULnerability in GEriatrics (DIVULGE) study: A protocol for a prospective observational study of electroencephalogram associations with incident postoperative delirium. BMJ Neurology Open, 3(2), e000199-1-e000199-8.
DOI Scopus3 WoS3 Europe PMC3
2020 Bogana Shanmugam, V., Psaltis, P. J., Tay, L., Malaiapan, Y., & Ahmar, W. (2020). Procedural and clinical outcomes in management of bifurcational lesions in ST elevation myocardial infarction. Heart Lung and Circulation, 29(2), 272-279.
DOI Scopus7 WoS6 Europe PMC5
2020 Carpenter, H. J., Gholipour, A., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2020). A review on the biomechanics of coronary arteries. International Journal of Engineering Science, 147, 1-62.
DOI Scopus61 WoS61
2020 Greaves, D., Psaltis, P., Lampit, A., Davis, D., Smith, A., Bourke, A., . . . Keage, H. (2020). Computerised cognitive training to improve cognition including delirium following coronary artery bypass grafting surgery: protocol for a blinded randomised controlled trial. BMJ Open, 10(2), e034551-1-e034551-11.
DOI Scopus24 WoS18 Europe PMC17
2020 Shishikura, D., Kataoka, Y., Di Giovanni, G., Takata, K., Scherer, D. J., Andrews, J., . . . Nicholls, S. J. (2020). Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events. European Heart Journal, 41(31), 2965-2973.
DOI Scopus36 WoS28 Europe PMC28
2020 Yuvaraj, J., Lin, A., Nerlekar, N., Rashid, H., Cameron, J. D., Seneviratne, S., . . . Wong, D. T. L. (2020). Is spontaneous coronary artery dissection (SCAD) related to vascular inflammation and epicardial fat? – insights from computed tomography coronary angiography. Cardiovascular Diagnosis and Therapy, 10(2), 239-241.
DOI Scopus11 WoS10 Europe PMC10
2020 Ghezzi, E. S., Ross, T. J., Davis, D., Psaltis, P. J., Loetscher, T., & Keage, H. A. D. (2020). Meta-analysis of prevalence and risk factors for cognitive decline and improvement after transcatheter aortic valve implantation. American Journal of Cardiology, 127, 105-112.
DOI Scopus40 WoS34 Europe PMC33
2020 Primer, K. R., Psaltis, P. J., Tan, J. T. M., & Bursill, C. A. (2020). The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis.. Int J Mol Sci, 21(10), 1-21.
DOI Scopus35 WoS31 Europe PMC31
2020 Gholipour, A., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2020). In vivo based biomechanics of right and left coronary arteries. International Journal of Engineering Science, 154, 103281-1-103281-31.
DOI Scopus23 WoS22
2020 Merrett, J. E., Xie, J., Psaltis, P. J., & Proud, C. G. (2020). MAPK-interacting kinase 2 (MNK2) regulates adipocyte metabolism independently of its catalytic activity. The Biochemical Journal, 477(14), 2735-2754.
DOI Scopus10 WoS10 Europe PMC9
2020 Baumann, A. A. W., Mishra, A., Worthley, M. I., Nelson, A. J., & Psaltis, P. J. (2020). Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine. Therapeutic Advances in Chronic Disease, 11, 1-23.
DOI Scopus44 WoS41 Europe PMC31
2020 Merrett, J. E., Bo, T., Psaltis, P. J., & Proud, C. G. (2020). Identification of DNA response elements regulating expression of CCAAT/enhancer-binding protein (C/EBP) β and δ and MAP kinase-interacting kinases during early adipogenesis. Adipocyte, 9(1), 427-442.
DOI Scopus28 WoS24 Europe PMC24
2020 Koerber, J. P., Bennetts, J. S., & Psaltis, P. J. (2020). Early Valve Replacement for Severe Aortic Valve Disease: Effect on Mortality and Clinical Ramifications.. Journal of clinical medicine, 9(9), 20 pages.
DOI Scopus11 WoS7 Europe PMC7
2020 Montarello, N. J., Nelson, A. J., Verjans, J., Nicholls, S. J., & Psaltis, P. J. (2020). The role of intracoronary imaging in translational research. Cardiovascular Diagnosis and Therapy, 10(5), 1480-1507.
DOI Scopus14 WoS11 Europe PMC8
2020 Greaves, D., Psaltis, P. J., Davis, D. H. J., Ross, T. J., Ghezzi, E. S., Lampit, A., . . . Keage, H. A. D. (2020). Risk factors for delirium and cognitive decline following coronary artery bypass grafting surgery: a systematic review and meta-analysis. Journal of the American Heart Association, 9(22), e017275-1-e017275-15[150].
DOI Scopus147 WoS129 Europe PMC125
2020 Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . FH Australasia Network Consensus Working Group. (2020). Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.. Heart Lung Circ, 30(3), 324-349.
DOI Scopus101 WoS96 Europe PMC85
2019 Shishikura, D., Kataoka, Y., Honda, S., Takata, K., Kim, S., Andrews, J., . . . Nicholls, S. (2019). The effect of bromodomain and extra-terminal inhibitor apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial. American Journal of Cardiovascular Drugs, 19(1), 49-57.
DOI Scopus37 WoS34 Europe PMC29
2019 Mridha, N., Subhaharan, D., Niranjan, S., Rashid, M. K., Psaltis, P., & Singh, K. (2019). A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents. European Heart Journal - Quality of Care and Clinical Outcomes, 5(2), 105-113.
DOI Scopus19 WoS19 Europe PMC13
2019 Majeed, K., Nelson, A. J., Psaltis, P. J., & Worthley, M. I. (2019). Direct-Acting Oral Anticoagulants: Less is not always more. Cor et Vasa, 61(4), 436-438.
DOI
2019 Vidanapathirana, A. K., Pullen, B. J., Zhang, R., Duong, M. N., Goyne, J. M., Zhang, X., . . . Psaltis, P. J. (2019). A novel ruthenium-based molecular sensor to detect endothelial nitric oxide. Scientific Reports, 9(1, article no. 1720), 1720-1-1720-16.
DOI Scopus10 WoS10 Europe PMC11
2019 Kiran Munnur, R., Andrews, J., Kataoka, Y., Psaltis, P., Nicholls, S., Malaiapan, Y., . . . Wong, D. (2019). Serial Coronary Plaque Assessment Using Computed Tomography Coronary Angiography: A Comparison With Intravascular Ultrasound. Circulation: Cardiovascular Imaging, 12(3), 3 pages.
DOI Scopus13 WoS13 Europe PMC10
2019 Toledo-Flores, D., Williamson, A., Schwarz, N., Fernando, S., Dimasi, C., Witt, T. A., . . . Psaltis, P. J. (2019). Vasculogenic properties of adventitial Sca-1⁺CD45⁺ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Scientific Reports, 9(1), 7286-1-7286-15.
DOI Scopus24 WoS22 Europe PMC24
2019 Greaves, D., Psaltis, P. J., Ross, T. J., Davis, D., Smith, A. E., Boord, M. S., & Keage, H. A. D. (2019). Cognitive outcomes following coronary artery bypass grafting: a systematic review and meta-analysis of 91,829 patients. International Journal of Cardiology, 289, 43-49.
DOI Scopus160 WoS135 Europe PMC124
2019 Opperman, K. S., Vandyke, K., Clark, K. C., Coulter, E. A., Hewett, D. R., Mrozik, K. M., . . . Zannettino, A. C. (2019). Clodronate-liposome mediated macrophage depletion abrogates multiple myeloma tumor establishment in vivo. Neoplasia, 21(8), 777-787.
DOI Scopus70 WoS66 Europe PMC61
2019 Franke, K. B., & Psaltis, P. J. (2019). Coronary Vasospasm Induced by Phentermine. Mayo Clinic Proceedings, 94(7), 1138-1140.
DOI Scopus1 WoS2 Europe PMC2
2019 Franke, K. B., Wong, D. T. L., Baumann, A., Nicholls, S. J., Gulati, R., & Psaltis, P. J. (2019). Current state-of-play in spontaneous coronary artery dissection. Cardiovascular Diagnosis and Therapy, 9(3), 281-298.
DOI Scopus27 WoS22 Europe PMC20
2019 Mridha, N., Subhaharan, D., Niranjan, S., Rashid, M. K., Psaltis, P., & Singh, K. (2019). Corrigendum to: A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents (European Heart Journal - Quality of Care and Clinical Outcomes (2018) DOI: 10.1093/ehjqcco/qcy036). European Heart Journal Quality of Care and Clinical Outcomes, 5(1), 82.
DOI
2019 Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019). Inflammation as a therapeutic target in atherosclerosis. Journal of Clinical Medicine, 8(8), 1109-1-1109-20.
DOI Scopus162 WoS145 Europe PMC121
2019 Takata, K., Honda, S., Sidharta, S. L., MyNgan, D., Shishikura, D., Kim, S. W., . . . Nicholls, S. J. (2019). Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 9(4), 310.
DOI Scopus10 WoS9 Europe PMC10
2019 Munnur, R. K., Andrews, J., Kataoka, Y., Nerlekar, N., Psaltis, P. J., Nicholls, S. J., . . . Wong, D. T. L. (2019). Quantitative and qualitative coronary plaque assessment using computed tomography coronary angiography: a comparison with intravascular ultrasound. Heart Lung and Circulation, 29(6), 883-893.
DOI Scopus10 WoS8 Europe PMC7
2019 Nelson, A. J., Ardissino, M., & Psaltis, P. J. (2019). Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers. Therapeutic Advances in Chronic Disease, 10, 1-20.
DOI Scopus42 WoS43 Europe PMC32
2019 Solly, E. L., Dimasi, C. G., Bursill, C. A., Psaltis, P. J., & Tan, J. T. M. (2019). MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis. Journal of Clinical Medicine, 8(12), 2199-1-2199-26.
DOI Scopus59 WoS56 Europe PMC49
2018 Beltrame, J., & Psaltis, P. (2018). The Forgotten Vascular Layer in the Forgotten Coronary Disorder. Journal of the American College of Cardiology, 71(4), 426-428.
DOI Scopus14 WoS14 Europe PMC12
2018 Tefft, B. J., Uthamaraj, S., Harbuzariu, A., Harburn, J. J., Witt, T. A., Newman, B., . . . Sandhu, G. S. (2018). Nanoparticle-mediated cell capture enables rapid endothelialization of a novel bare metal stent. Tissue Engineering: Part A, 24(13-14), 1157-1166.
DOI Scopus19 WoS19 Europe PMC14
2018 Sidharta, S. L., Baillie, T. J., Howell, S., Nicholls, S. J., Montarello, N., Honda, S., . . . Worthley, M. I. (2018). Evaluation of human coronary vasodilator function predicts future coronary atheroma progression. Heart, 104(17), 1439-1446.
DOI Scopus1 WoS1 Europe PMC1
2018 Nicholls, S., & Psaltis, P. (2018). Lipid lowering in acute coronary syndrome: is treatment early enough?. Journal of the American Medical Association, 319(13), 1325-1326.
DOI Scopus4 WoS4 Europe PMC5
2018 Andrews, J., Psaltis, P. J., Bartolo, B., Nicholls, S. J., & Puri, R. (2018). Coronary arterial calcification: A review of mechanisms, promoters and imaging. Trends in Cardiovascular Medicine, 28(8), 491-501.
DOI Scopus91 WoS77 Europe PMC68
2018 Shishikura, D., Sidharta, S. L., Honda, S., Takata, K., Kim, S. W., Andrews, J., . . . Nicholls, S. J. (2018). The relationship between segmental wall shear stress and lipid core plaque derived from near-infrared spectroscopy. Atherosclerosis, 275, 68-73.
DOI Scopus19 WoS18 Europe PMC15
2018 Munnur, R., Cameron, J., McCormick, L., Psaltis, P., Nerlekar, N., Ko, B., . . . Wong, D. (2018). Diagnostic accuracy of ASLA score (a novel CT angiographic index) and aggregate plaque volume in the assessment of functional significance of coronary stenosis. International Journal of Cardiology, 270, 343-348.
DOI Scopus4 WoS3 Europe PMC4
2018 Schwarz, N., Nicholls, S. J., & Psaltis, P. J. (2018). Vitamin D and cardiovascular disease. Heart Lung and Circulation, 27(8), 903-906.
DOI Scopus4 WoS4 Europe PMC4
2018 Nicholls, S., Andrews, J., Kastelein, J., Merkely, B., Nissen, S., Ray, K., . . . Butters, J. (2018). Effect of serial infusions of CER-001, a pre-β High-density lipoprotein mimetic, on coronary atherosclerosis in patients following acute coronary syndromes in the CER-001 atherosclerosis regression acute coronary syndrome trial: A randomized clinical trial. JAMA Cardiology, 3(9), 815-822.
DOI Scopus175 WoS160 Europe PMC141
2018 Di Bartolo, B., Psaltis, P., Bursill, C., & Nicholls, S. (2018). Translating evidence of HDL and plaque regression. Arteriosclerosis, thrombosis, and vascular biology, 38(9), 1961-1968.
DOI Scopus25 WoS25 Europe PMC24
2018 Tilley, E., Psaltis, P., Loetscher, T., Davis, D., Harrison, S., Kim, S., & Keage, H. (2018). Meta-analysis of prevalence and risk factors for delirium after transcatheter aortic valve implantation. American Journal of Cardiology, 122(11), 1917-1923.
DOI Scopus62 WoS60 Europe PMC52
2017 Nicholls, S., Andrews, J., & Psaltis, P. (2017). Using imaging to identify the high-risk diabetic patient: are we any closer?. JACC: Cardiovascular Imaging, 10(4), 459-460.
DOI
2017 Kataoka, Y., Andrews, J., Puri, R., Psaltis, P., & Nicholls, S. (2017). Plaque burden, microstructures and compositions underachieving very low LDL-C levels. Current Opinion in Endocrinology, Diabetes and Obesity, 24(2), 122-132.
DOI Scopus8 WoS8 Europe PMC7
2017 Sundararajan, K., Roberts-Thomson, R. L., Nelson, A. J., & Psaltis, P. J. (2017). Therapeutic paradox: nimodipine attenuates severe coronary spasm following coronary artery graft surgery in a high-risk vasoplegic cancer patient. Internal Medicine Journal, 47(2), 229-231.
DOI Scopus1 WoS1
2017 Potter, E., Machado, C., Malaiapan, Y., Narayan, O., Ko, B., Psaltis, P., . . . Wong, D. (2017). Stenotic flow reserve derived from quantitative coronary angiography has modest but incremental value in predicting functionally significant coronary stenosis as evaluated by fractional flow reserve. Cardiovascular Diagnosis and Therapy, 7(1), 52-59.
DOI Scopus4 WoS4 Europe PMC3
2017 Kataoka, Y., Andrews, J., Puri, R., Psaltis, P., & Nicholls, S. (2017). Lipid lowering therapy to modify plaque microstructures: Insights from optical coherence tomography imaging. Journal of Atherosclerosis and Thrombosis, 24(4), 360-372.
DOI Scopus10 WoS7 Europe PMC7
2017 Scherer, D., Nelson, A., Psaltis, P., & Nicholls, S. (2017). Targeting low-density lipoprotein cholesterol with PCSK9 Inhibitors. Internal medicine journal, 47(8), 856-865.
DOI Scopus25 WoS21 Europe PMC18
2017 Nicholls, S. J., & Psaltis, P. J. (2017). What role for lipoprotein(a) in clinical practice?. Lancet Diabetes and Endocrinology, 5(7), 487-489.
DOI Scopus4 WoS5 Europe PMC3
2017 Di Bartolo, B., Scherer, D. J., Brown, A., Psaltis, P. J., & Nicholls, S. J. (2017). PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook. Biodrugs, 31(3), 167-174.
DOI Scopus14 WoS10 Europe PMC9
2017 Takata, K., Psaltis, P. J., & Nicholls, S. J. (2017). Investigating the long-term legacy of statin therapy. Journal of Thoracic Disease, 9(4), 936-939.
DOI Scopus5 WoS5 Europe PMC5
2017 Shanmugam, V., Psaltis, P., Wong, D., Meredith, I., Malaiapan, Y., & Ahmar, W. (2017). Outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction caused by ectatic infarct related arteries. Heart, Lung and Circulation, 26(10), 1059-1068.
DOI Scopus52 WoS40 Europe PMC44
2017 Andrews, J., Psaltis, P. J., Bayturan, O., Shao, M., Stegman, B., Elshazly, M., . . . Puri, R. (2017). Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound.. JACC: Cardiovascular Imaging, 11(9), 1315-1323.
DOI Scopus53 WoS48 Europe PMC50
2017 Stokes, M., Sanders, P., Nicholls, S., & Psaltis, P. (2017). NSAID use and cardiovascular disease - A cautionary tale. Heart, Lung and Circulation, 26(8), 753-756.
DOI Scopus3 WoS2 Europe PMC2
2017 Honda, S., Sidharta, S., Shishikura, D., Takata, K., Di Giovanni, G., Nguyen, T., . . . Nicholls, S. (2017). High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy. Atherosclerosis, 265, 110-116.
DOI Scopus18 WoS17 Europe PMC14
2017 Chen, X., Duong, M., Psaltis, P., Bursill, C., & Nicholls, S. (2017). High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes. Cardiovascular Diabetology, 16(1), 121-1-121-9.
DOI Scopus17 WoS19 Europe PMC18
2017 Heng, S., Reineck, P., Vidanapathirana, A., Pullen, B., Drumm, D., Ritter, L., . . . Abell, A. (2017). Rationally designed probe for reversible sensing of zinc and application in cells. ACS Omega, 2(9), 6201-6210.
DOI Scopus26 WoS25 Europe PMC12
2017 Purdey, M. S., Capon, P. K., Pullen, B. J., Reineck, P., Schwarz, N., Psaltis, P. J., . . . Abell, A. D. (2017). An organic fluorophore-nanodiamond hybrid sensor for photostable imaging and orthogonal, on-demand biosensing. Scientific Reports, 7(1), 15967-1-15967-8.
DOI Scopus15 WoS13 Europe PMC3
2017 Shanmugam, V., Wong, D., Rashid, H., Cameron, J., Malaiapan, Y., & Psaltis, P. (2017). Bleeding outcomes after non-emergency percutaneous coronary intervention in the very elderly. Journal of Geriatric Cardiology, 14(10), 624-631.
DOI Scopus6 WoS4 Europe PMC2
2016 Psaltis, P. J., Talman, A. H., Munnur, K., Cameron, J. D., Ko, B. S. H., Meredith, I. T., . . . Wong, D. T. L. (2016). Relationship between epicardial fat and quantitative coronary artery plaque progression: insights from computer tomography coronary angiography. International Journal of Cardiovascular Imaging, 32(2), 317-328.
DOI Scopus24 WoS23 Europe PMC17
2016 Rashid, H., Wong, D., Wijesekera, H., Gutman, S., Shanmugam, V., Gulati, R., . . . Psaltis, P. (2016). Incidence and characterisation of spontaneous coronary artery dissection as a cause of acute coronary syndrome - A single-centre Australian experience. International Journal of Cardiology, 202, 336-338.
DOI Scopus176 WoS160 Europe PMC154
2016 Psaltis, P. J., & Nicholls, S. J. (2016). Management of acute coronary syndrome in the very elderly. Lancet, 387(10023), 1029-1030.
DOI Scopus12 WoS10 Europe PMC9
2016 Potter, E. L., Meredith, I. T., & Psaltis, P. J. (2016). ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: An important sequela of Kawasaki disease and a management challenge. BMJ Case Reports, 2016, bcr2015213622.
DOI Scopus6 Europe PMC5
2016 BoganaShanmugam, V., Psaltis, P., Wong, D., Seneviratne, S., Cameron, J., Meredith, I., & Malaiapan, Y. (2016). Chronic Total Occlusion - Percutaneous Coronary Intervention (CTO-PCI) Experience in a Single, Multi-operator Australian Centre: Need for dedicated CTO-PCI programs. Heart Lung and Circulation, 25(7), 676-682.
DOI Scopus6 WoS3 Europe PMC5
2016 Psaltis, P. J., & Nicholls, S. J. (2016). Imaging: Focusing light on the vulnerable plaque. Nature Reviews Cardiology, 13(5), 253-255.
DOI Scopus8 WoS6 Europe PMC4
2016 Nicholls, S. J., Kataoka, Y., & Psaltis, P. J. (2016). Shining the light on calcium in the catheterization lab. Circulation Journal, 80(6), 1319-1320.
DOI
2016 Psaltis, P. J., Schwarz, N., Toledo-Flores, D., & Nicholls, S. J. (2016). Cellular therapy for heart failure. Current Cardiology Reviews, 12(3), 195-215.
DOI Scopus25 WoS22 Europe PMC21
2016 Andrews, J., Puri, R., Kataoka, Y., Nicholls, S., & Psaltis, P. (2016). Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies. Cardiovascular diagnosis and therapy, 6(4), 282-303.
DOI Scopus12 WoS11 Europe PMC11
2016 Scherer, D., & Psaltis, P. (2016). Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with ¹⁸F positron emission tomography. Cardiovascular Diagnosis and Therapy, 6(4), 354-367.
DOI Scopus14 WoS13 Europe PMC10
2016 Keage, H. A. D., Smith, A., Loetscher, T., & Psaltis, P. (2016). Cognitive outcomes of cardiovascular surgical procedures in the old: an important but neglected area. Heart lung and circulation, 25(12), 1148-1153.
DOI Scopus10 WoS9 Europe PMC9
2016 Nicholls, S. J., & Psaltis, P. J. (2016). Will Big Data Shine Light at the End of the Tunnel for HDL?. Journal of the American College of Cardiology, 68(19), 2084-2085.
DOI Scopus3 WoS2 Europe PMC3
2016 Raphael, C., Spoon, D., Bell, M., Psaltis, P., Kidd, S., Loh, S., . . . Gulati, R. (2016). Effect of Preprocedural Thrombocytopenia on Prognosis After Percutaneous Coronary Intervention. Mayo Clinic Proceedings, 91(8), 1035-1044.
DOI Scopus27 WoS27 Europe PMC21
2016 Boganashanmugam, V., Psaltis, P. J., & Antonis, P. (2016). Intravascular ultrasound-guided management of large thrombus burden in an aneurysmal coronary artery in a young male. Catheterization and Cardiovascular Interventions, 88(6), E198-E202.
DOI Scopus1 WoS1 Europe PMC1
2016 Loh, S., Spoon, D., Singh, M., Psaltis, P., Lennon, R., Holmes, D., & Gulati, R. (2016). Cause of long-term mortality among diabetics undergoing percutaneous coronary intervention. Clinical Medicine Journal of the Royal College of Physicians of London, 16(3), s9.
DOI
2015 Psaltis, P., & Simari, R. (2015). Vascular wall progenitor cells in health and disease. Circulation Research, 116(8), 1392-1412.
DOI Scopus172 WoS161 Europe PMC149
2015 Spoon, D., Lennon, R., Psaltis, P., Prasad, A., Holmes, D., Lerman, A., . . . Gulati, R. (2015). Prediction of cardiac and noncardiac mortality after percutaneous coronary intervention. Circulation: Cardiovascular Interventions, 8(9), e002121-1-e002121-39.
DOI Scopus13 WoS14 Europe PMC12
2015 Franchi, F., Peterson, K., Xu, R., Miller, B., Psaltis, P., Harris, P., . . . Rodriguez-Porcel, M. (2015). Mesenchymal stromal cells improve renovascular function in polycystic kidney disease. Cell Transplantation, 24(9), 1687-1698.
DOI Scopus28 WoS23 Europe PMC19
2015 Shanmugam, V., Harper, R., Meredith, I., Malaiapan, Y., & Psaltis, P. (2015). An overview of PCI in the very elderly. Journal of Geriatric Cardiology, 12(2), 174-184.
DOI Scopus100 WoS87 Europe PMC73
2014 Wong, T., Leong, D., Weightman, M., Richardson, J., Dundon, B., Psaltis, P., . . . Worthley, S. (2014). Magnetic resonance-derived circumferential strain provides a superior and incremental assessment of improvement in contractile function in patients early after ST-segment elevation myocardial infarction. European Radiology, 24(6), 1219-1228.
DOI Scopus20 WoS20 Europe PMC17
2014 Chokka, R., Delacroix, S., Psaltis, P., Anavekar, N., & Worthley, S. (2014). Percutaneous renal denervation and the second generation EnligHTN system. Minerva Cardioangiologica, 62(1), 99-104.
Scopus5 WoS4 Europe PMC3
2014 Richardson, J., Psaltis, P., Frost, L., Paton, S., Carbone, A., Bertaso, A., . . . Worthley, S. (2014). Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy, 16(4), 460-470.
DOI Scopus24 WoS24 Europe PMC23
2014 Psaltis, P., Spoon, D., Wong, D., & Gulati, R. (2014). An update on stem cell therapies for acute coronary syndrome. Current Cardiology Reports, 16(9), 526-538.
DOI Scopus5 WoS4 Europe PMC4
2014 Psaltis, P., Puranik, A., Spoon, D., Chue, C., Hoffman, S., Witt, T., . . . Simari, R. (2014). Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature. Circulation Research, 115(3), 364-375.
DOI Scopus91 WoS89 Europe PMC82
2014 Malaiapan, Y., Wong, D. T. L., Psaltis, P. J., & Meredith, I. T. (2014). Authors' reply. The Lancet, 383(9932), 1888.
DOI
2014 Talman, A. H., Psaltis, P. J., Cameron, J. D., Meredith, I. T., Seneviratne, S. K., & Wong, D. T. (2014). Epicardial adipose tissue: far more than a fat depot.. Cardiovascular diagnosis and therapy, 4(6), 416-429.
DOI WoS224 Europe PMC180
2014 Spoon, D., Psaltis, P., Singh, M., Holmes, D., Gersh, B., Rihal, C., . . . Gulati, R. (2014). Trends in cause of death after percutaneous coronary intervention. Circulation, 129(12), 1286-1294.
DOI Scopus172 WoS169 Europe PMC150
2014 Psaltis, P. J., Meredith, I. T., & Ahmar, W. (2014). Case report survival with good neurological outcome in a patient with prolonged ischemic cardiac arrest-utility of automated chest compression systems in the cardiac catheterization laboratory. Catheterization and Cardiovascular Interventions, 84(6), 987-991.
DOI Scopus1 WoS1 Europe PMC1
2013 Psaltis, P., Spoon, D., & Wong, T. (2013). Utility of mesenchymal stromal cells for myocardial infarction. Transitioning from bench to bedside. Minerva Cardioangiologica, 61(6), 639-663.
Scopus8 WoS6 Europe PMC4
2013 Richardson, J., Bertaso, A., Frost, L., Psaltis, P., Carbone, A., Koschade, B., . . . Worthley, S. (2013). Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of invivo assessment of ventricular function in rats. Laboratory Animals, 47(4), 291-300.
DOI Scopus7 WoS6 Europe PMC5
2013 Richardson, J., Bertaso, A., Psaltis, P., Frost, L., Carbone, A., Paton, S., . . . Worthley, S. (2013). Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. Journal of Cardiac Failure, 19(5), 342-353.
DOI Scopus49 WoS45 Europe PMC39
2013 Richardson, J., Nelson, A., Zannettino, A., Gronthos, S., Worthley, S., & Psaltis, P. (2013). Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Reviews, 9(3), 281-302.
DOI Scopus24 WoS23 Europe PMC25
2013 Peterson, K., Franchi, F., Loeffler, D., Psaltis, P., Harris, P., Lerman, L., . . . Rodriguez-Porcel, M. (2013). Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease. American Journal of Nephrology, 38(3), 233-240.
DOI Scopus21 WoS21 Europe PMC19
2013 Psaltis, P., Peterson, K., Xu, R., Franchi, F., Witt, T., Chen, I., . . . Rodriguez-Porcel, M. (2013). Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells. JACC: Cardiovascular Imaging, 6(7), 795-802.
DOI Scopus33 WoS31 Europe PMC25
2013 Spoon, D., Rubinshtein, R., Psaltis, P., Sandhu, G., Lennon, R., Rihal, C., & Lerman, A. (2013). Comparison between three-dimensional angiographic reconstruction and intravascular ultrasound: imaging of the left main coronary artery. Catheterization and Cardiovascular Interventions, 81(7), 1156-1161.
DOI Scopus8 WoS7 Europe PMC3
2013 Xu, R., Franchi, F., Miller, B., Crane, J., Peterson, K., Psaltis, P., . . . Rodriguez-Porcel, M. (2013). Polycystic Kidneys Have Decreased Vascular Density: A Micro-CT Study. Microcirculation, 20(2), 183-189.
DOI Scopus36 WoS32 Europe PMC30
2013 Wong, D. T., Puri, R., Psaltis, P. J., Worthley, S. G., & Worthley, M. I. (2013). Acute ST-segment myocardial infarction-evolution of treatment strategies. World Journal of Cardiovascular Diseases, 03(09), 551-560.
DOI
2013 Delacroix, S., Psaltis, P., Worthley, M., & Worthley, S. (2013). Transradial access for ACS and STEMI. Cardiac Interventions Today, (July-August), 49-52.
2012 Carbone, A., Psaltis, P., Nelson, A., Metcalf, R., Richardson, J., Weightman, M., . . . Worthley, S. (2012). Dietary omega-3 supplementation exacerbates left ventricular dysfunction in an ovine model of anthracycline-induced cardiotoxicity. Journal of Cardiac Failure, 18(6), 502-511.
DOI Scopus17 WoS17 Europe PMC15
2012 Nelson, A. J., Puri, R., Psaltis, P. J., Sanders, P., & Young, G. D. (2012). Reply: Lead-preserving strategies for pacemaker pocket infection: Who, when and how?. Indian Pacing and Electrophysiology Journal, 12(6), 294-296.
DOI
2012 Hoffman, S., Psaltis, P., Clark, K., Spoon, D., Chue, C., Ekker, S., & Simari, R. (2012). An in vivo method to quantify lymphangiogenesis in zebrafish. PLoS ONE, 7(9), e45240-1-e45240-8.
DOI Scopus8 WoS8 Europe PMC8
2012 Psaltis, P. J., Simari, R. D., & Rodriguez-Porcel, M. (2012). Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging, 39(1), 165-181.
DOI Scopus13 WoS11 Europe PMC11
2012 Psaltis, P. J. (2012). Mechanistic insights into arterial repair with mesenchymal stromal cells: Editorial to: "stem cell therapy for arterial restenosis: Potential parameters contributing to the success of bone marrow-derived mesenchymal stromal cells" by A. Forte et al.. Cardiovascular Drugs and Therapy, 26(1), 1-3.
DOI Scopus1 WoS1 Europe PMC3
2012 Holroyd, E., Delacroix, S., Larsen, K., Harbuzariu, A., Psaltis, P., Wang, L., . . . Simari, R. (2012). Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(3), 704-711.
DOI Scopus26 WoS25 Europe PMC24
2012 Psaltis, P., Harbuzariu, A., Delacroix, S., Witt, T., Holroyd, E., Spoon, D., . . . Simari, R. (2012). Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta. Circulation, 125(4), 592-603.
DOI Scopus63 WoS64 Europe PMC63
2011 Lau, D., Psaltis, P., Mackenzie, L., Kelly, D., Carbone, A., Worthington, M., . . . Sanders, P. (2011). Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: remodeling of the same sort. Journal of Cardiovascular Electrophysiology, 22(2), 175-182.
DOI Scopus41 WoS38 Europe PMC32
2011 Lau, D., Psaltis, P., Carbone, A., Kelly, D., Mackenzie, L., Worthington, M., . . . Sanders, P. (2011). Atrial protective effects of n-3 polyunsaturated fatty acids: A long-term study in ovine chronic heart failure. Heart Rhythm, 8(4), 575-582.
DOI Scopus26 WoS23 Europe PMC22
2011 See, F., Seki, T., Psaltis, P., Sondermeijer, H., Gronthos, S., Zannettino, A., . . . Itescu, S. (2011). Therapeutic Effects of Human STRO-3-Selected Mesenchymal Precursor Cells and their Soluble Factors in Experimental Myocardial Ischemia. Journal of Cellular and Molecular Medicine, 15(10), 2117-2129.
DOI Scopus57 WoS52 Europe PMC47
2011 Psaltis, P., Carbone, A., Leong, D., Lau, D., Nelson, A., Kuchel, T., . . . Worthley, S. (2011). Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. International Journal of Cardiovascular Imaging, 27(1), 25-37.
DOI Scopus32 WoS29 Europe PMC28
2011 Puri, R., Psaltis, P., Nelson, A., Sanders, P., & Young, G. (2011). Povidone-iodine irrigation - a possible alternative to lead extraction. Indian Pacing and Electrophysiology Journal, 11(4), 115-119.
Scopus13 Europe PMC13
2011 Psaltis, P., & Simari, R. (2011). Cell therapy for refractory angina: Time for more ACTion. Stem Cell Research and Therapy, 2(6), 43.
DOI Scopus1 WoS1 Europe PMC1
2011 Psaltis, P., Harbuzariu, A., Delacroix, S., Holroyd, E., & Simari, R. (2011). Resident vascular progenitor cells-diverse origins, phenotype, and function. Journal of Cardiovascular Translational Research, 4(2), 161-176.
DOI Scopus92 WoS78 Europe PMC67
2010 Psaltis, P., Carbone, A., Nelson, A., Lau, D., Jantzen, T., Manavis, J., . . . Worthley, S. (2010). Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. JACC: Cardiovascular Interventions, 3(9), 974-983.
DOI Scopus67 WoS57 Europe PMC51
2010 Lau, D., Mackenzie, L., Kelly, D., Psaltis, P., Brooks, A., Worthington, M., . . . Sanders, P. (2010). Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm, 7(9), 1282-1290.
DOI Scopus175 WoS153 Europe PMC155
2010 Psaltis, P., Paton, S., See, F., Arthur, A., Martin, S., Itescu, S., . . . Zannettino, A. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Journal of Cellular Physiology, 223(2), 530-540.
DOI Scopus136 WoS125 Europe PMC118
2010 Lau, D., Mackenzie, L., Rajendram, A., Psaltis, P., Kelly, D., Spyropoulos, P., . . . Sanders, P. (2010). Characterization of cardiac remodeling in a large animal "one-kidney, one-clip" hypertensive model. Blood Pressure, 19(2), 119-125.
DOI Scopus18 WoS15 Europe PMC19
2010 Lau, D., Mackenzie, L., Kelly, D., Psaltis, P., Worthington, M., Rajendram, A., . . . Sanders, P. (2010). Short-term hypertension is associated with the development of atrial fibrillation substrate: A study in an ovine hypertensive model. Heart Rhythm, 7(3), 396-404.
DOI Scopus99 WoS91 Europe PMC93
2010 Psaltis, P., Zannettino, A., Gronthos, S., & Worthley, S. (2010). Intramyocardial navigation and mapping for stem cell delivery. Journal of Cardiovascular Translational Research, 3(2 Sp Iss), 135-146.
DOI Scopus30 WoS24 Europe PMC20
2009 Thavapalachandran, S., Leong, D., Stiles, M., John, B., Dimitri, H., Lau, D., . . . Sanders, P. (2009). Evidence-based management of heart failure in clinical practice: a review of device-based therapy use. Internal Medicine Journal, 39(10), 669-675.
DOI Scopus6 WoS4 Europe PMC4
2009 Nelson, A., Worthley, M., Psaltis, P., Carbone, A., Dundon, B., Duncan, R., . . . Worthley, S. (2009). Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. Journal of Cardiovascular Magnetic Resonance, 11(1), 1-8.
DOI Scopus116 WoS117 Europe PMC110
2009 Puri, R., Dundon, B. K., Psaltis, P. J., Worthley, S. G., & Worthley, M. I. (2009). Inadvertent anastomosis of internal mammary artery to great cardiac vein: A rare complication of coronary artery bypass surgery. Texas Heart Institute Journal, 36(6), 626-627.
Scopus6 WoS5 Europe PMC3
2009 Psaltis, P. J., & Worthley, S. G. (2009). Endoventricular electromechanical mapping - the diagnostic and therapeutic utility of the NOGA® XP cardiac navigation system. Journal of Cardiovascular Translational Research, 2(1), 48-62.
DOI Scopus30 WoS26 Europe PMC25
2009 Psaltis, P. J., Carbone, A., Lau, D., Jantzen, T., Williams, K., Sanders, P., . . . Worthley, S. G. (2009). Purkinje fiber injury and electrical remodeling in non-ischemic cardiomyopathy: Implications for sudden cardiac death. EUROPEAN HEART JOURNAL, 30, 558.
2009 Psaltis, P. J., See, F., Paton, S., Martens, T. P., Itescu, S., Worthley, S. G., . . . Zannettino, A. C. W. (2009). STRO-1 immunoselection enhances the biological properties and cardiovascular paracrine effects of bone marrow mesenchymal stromal cells. EUROPEAN HEART JOURNAL, 30, 501.
2008 Dundon, B., Psaltis, P., & Worthley, S. (2008). Cardiac magnetic resonance and "augmented" right-to-left intracardiac shunting through a patent foramen ovale. Journal of Invasive Cardiology, 20(4), 197-198.
Scopus10 WoS10 Europe PMC8
2008 Psaltis, P., Carbone, A., Nelson, A., Lau, D., Manavis, J., Finnie, J., . . . Worthley, S. (2008). An ovine model of toxic, nonischemic cardiomyopathy-assessment by cardiac magnetic resonance imaging. Journal of Cardiac Failure, 14(9), 785-795.
DOI Scopus26 WoS19 Europe PMC15
2008 Psaltis, P., Zannettino, A., Worthley, S., & Gronthos, S. (2008). Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells, 26(9), 2201-2210.
DOI Scopus313 WoS264 Europe PMC230
2008 Psaltis, P., Dundon, B., Teo, K., & Worthley, S. (2008). Utility of Cardiac Magnetic Resonance Imaging in Detection of Post-Infarction Intra-Myocardial Dissection. Heart, Lung & Circulation (Print Edition), 17(5), 415-416.
DOI Scopus3 WoS3 Europe PMC3
2008 Athanasos, P., Farquharson, A., Compton, P., Psaltis, P., & Hay, J. (2008). Electrocardiogram characteristics of methadone and buprenorphine maintained subjects. Journal of Addictive Diseases, 27(3), 31-35.
DOI Scopus36 WoS30 Europe PMC23
2008 Zannettino, A., Psaltis, P., & Gronthos, S. (2008). Home is where the heart is: Via the FROUNT. Cell Stem Cell, 2(6), 513-514.
DOI Scopus3 WoS3 Europe PMC3
2008 Psaltis, P. J., Gronthos, S., Worthley, S. G., & Zannettino, A. C. W. (2008). Cellular therapy for cardiovascular disease Part 1 - Preclinical insights. Clinical Medicine Insights : Cardiology, 2, 125-138.
2008 Psaltis, P. J., Gronthos, S., Worthley, S. G., & Zannettino, A. C. W. (2008). Cellular therapy for cardiovascular disease Part 2 - Delivery of cells and clinical experience. Clinical Medicine Insights : Cardiology, 2, 139-151.
WoS3
2007 Psaltis, P., Dundon, B., & Leong, D. (2007). Acute anaphylaxis following exercise stress testing. Internal Medicine Journal, 37(5), 343A-344.
DOI Scopus1 WoS1 Europe PMC1
2006 Roberts-Thomson, K., Psaltis, P., & DeAngelis, E. (2006). Cardiogenic shock in a young woman. Cardiology: international journal of cardiovascular medicine, surgery and pathology, 105(3), 182-183.
DOI Scopus1 WoS1 Europe PMC1

Year Citation
2022 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2022). Effect of Nonlinear Blood Viscosity on LDL Transport and Fluid-Structure Interaction Biomechanics of a Multi-stenosis Left Circumflex Coronary Artery. In W. Lacarbonara (Ed.), NODYCON Conference Proceedings Series (pp. 39-48). Springer International Publishing.
DOI
2021 Gholipour, A., Carpenter, H. J., Hajghayesh, M. H., Zander, A., & Psaltis, P. J. (2021). Effect of Blood Flow Models on the Flow-Induced Vibrations of Coronary Arteries. In S. Oberst, B. Halkon, & J. Ji (Eds.), Vibration Engineering for a Sustainable Future (Vol. 3, pp. 345-351). Switzerland: Springer International Publishing.
DOI
2020 Nankivell, V., Primer, K., Vidanapathirana, A., Psaltis, P., & Bursill, C. (2020). Vascular Biology of Smooth Muscle Cells and Restenosis. In R. Fitridge (Ed.), Mechanisms of Vascular Disease A Textbook for Vascular Specialists (3rd ed., pp. 117-139). Cham, Switzerland: Springer.
Scopus7
2020 Fernando, S., Bursill, C. A., Nicholls, S. J., & Psaltis, P. J. (2020). Pathophysiology of Atherosclerosis. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists Third Edition (pp. 19-45). Springer International Publishing.
DOI Scopus7

Year Citation
2025 O'Brien, J., Easey, K., Redwood, E., Ford, T., Marathe, J., Psaltis, P., . . . Wong, D. (2025). A Prospective Observational Study of Diagnostic Accuracy and Feasibility of Quantitative Flow Ratio When Compared to Fractional Flow Reserve. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 85 (pp. 2 pages). SOUTH KOREA, Seoul: ELSEVIER SCIENCE INC.
2024 Dang, Q., Psaltis, P., Burgess, S., Chandrasekhar, J., Mukherjee, S., Kritharides, L., . . . Zaman, S. (2024). Predictors of Major Adverse Cardiovascular Events: First Report From the Australian-New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry. In Heart Lung and Circulation Vol. 33 (pp. S366-S367). Elsevier BV.
DOI
2024 Solly, E. L., Bouman Chen, Z., Luo, Y., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., . . . Tan, J. T. M. (2024). Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1. In EUROPEAN HEART JOURNAL Vol. 45 (pp. 1 page). ENGLAND, London: OXFORD UNIV PRESS.
DOI WoS1
2024 Bursill, C., Pullen, B. J., Debebe, D., Sandeman, L., Wattchow, N. E., Vidanapathirana, A., . . . Packer, N. H. (2024). Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo. In Abstracts of the European Society of Cardiology Congress (ESC, 2024) as published in European Heart Journal Vol. 45 (pp. ehae6663875-1). London, England and Virtual Online: Oxford University Press.
DOI
2024 Bursill, C., Sandeman, L., Layland, M., Lee, D., Nankivell, V., Tan, J., . . . Abell, A. (2024). DIROXIMEL FUMARATE REDUCES ATHEROSCLEROTIC PLAQUE SIZE AND INSTABILITY. In ATHEROSCLEROSIS Vol. 399 (pp. 2 pages). OMAN, Muscat: ELSEVIER IRELAND LTD.
DOI
2023 Liyanage, S., Williamson, A., Salagaras, T., Hassanshahi, M., Long, A., Tran, D., . . . Psaltis, P. (2023). Inhibitory And Metabolic Effects Of Diabetes On Yolk Sacderived Endothelial-macrophage Progenitors In Postnatal Murine Tissues. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 43 (pp. 2 pages). PA, Philadelphia: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2022 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., & Psaltis, P. J. (2022). Wall Shear Stress for an Aorta with Aneurysms Via Computational Fluid Dynamics. In Advances in Nonlinear Dynamics. NODYCON Conference Proceedings Series (pp. 27-37). Switzerland: Springer International Publishing.
DOI
2022 Solly, E. L., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2022). Inhibition of microRNA-181c rescues diabetes-impaired angiogenesis through activation of key angiogenesis mediators. In DIABETOLOGIA Vol. 65 (pp. S25-S26). Stockholm, SWEDEN: SPRINGER.
2022 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., & Psaltis, P. J. (2022). Dynamical influences of different aneurysm sizes on rupture risk of abdominal aorta. In Proceedings of the 1st International Conference on Mechanical System Dynamics (ICMSD 2022) Vol. 2022 (pp. 33-38). Hybrid Conference, Nanjing, China: Institution of Engineering and Technology.
DOI Scopus1
2021 Carpenter, H. J., Gholipour, A., Hajghayesh, M., Zander, A., & Psaltis, P. J. (2021). Flow-Induced Dynamics of Bifurcated Coronary Arteries. In Vibration Engineering for a Sustainable Future: Numerical and Analytical Methods to Study Dynamical Systems, Vol. 3 (pp. 339-344). Switzerland: Springer International Publishing.
DOI Scopus1
2021 Heath, S. J., Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2021). Fluid-Elastic Versus Computational Fluid Dynamics Techniques in the Biomechanical Analysis of Coronary Arteries. In 10th Australasian Congress on Applied Mechanics 2021, ACAM 2021 (pp. 686-698). Virtual, Online: Engineers Australia.
2021 Hiwase, D., Leslie, A., Montarello, N., Friel, O., Chhetri, R., & Psaltis, P. (2021). BURDEN AND MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN MYELODYSPLASTIC SYNDROME (MDS). In LEUKEMIA RESEARCH Vol. 108 (pp. S8). PERGAMON-ELSEVIER SCIENCE LTD.
2020 Carpenter, H. J., Gholipour, A., Ghayesh, M. H., Zander, A., & Psaltis, P. J. (2020). IN VIVO BASED BIOMECHANICS OF THE LEFT MAIN CORONARY BIFURCATION REGION. In ATHEROSCLEROSIS Vol. 315 (pp. E23). ELSEVIER IRELAND LTD.
2019 Pisaniello, A. D., King, P., Di Bartolo, B. A., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Nicholls, S. (2019). IMPACT OF FISH OIL SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN HEALTHY VOLUNTEERS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2091). New Orleans, LA: ELSEVIER SCIENCE INC.
DOI
2019 Bursill, C., Primer, K. R., Solly, E., Psaltis, P. J., & Tan, J. T. M. (2019). High-density lipoproteins rescue diabetes-impaired angiogenesis by restoring cellular metabolic reprogramming responses to hypoxia. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 337). FRANCE, Paris: OXFORD UNIV PRESS.
WoS1
2018 Gholipour, A., Ghayesh, M., Zander, A., Nicholls, S., & Psaltis, P. (2018). Fluid-structure analysis of an atherosclerotic coronary artery. In Proceedings of the 21st Australasian Fluid Mechanics Conference (AFMC 2018) (pp. 1-4). Adelaide, Australia: Australian Fluid Mechanics Society.
Scopus1
2018 Akers, E. J., Mulangala, J., Psaltis, P. J., Bursill, C., Nicholls, S. J., & Di Bartolo, B. A. (2018). Lipoproteins and their Modified Forms Regulate Smooth Muscle Cell Calcification. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). CA, San Francisco: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2018 Mulangala, J., Akers, E. J., Solly, E. L., Psaltis, P. J., Tan, J. T., Nicholls, S. J., . . . Di Bartolo, B. A. (2018). Elevated Calcium Drives Inflammatory-Driven Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). CA, San Francisco: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2018 Shanmugam, V. B., & Psaltis, P. (2018). BIFURCATIONAL PERCUTANEOUS CORONARY INTERVENTION IN ST ELEVATION MYOCARDIAL INFARCTION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 72 (pp. B165). CA, San Diego: ELSEVIER SCIENCE INC.
2018 Shishikura, D., Kataoka, Y., Di Giovanni, G., Janssan, A., Takata, K., Andrews, J., . . . Nicholls, S. (2018). Progression of Plaque Attenuation and Echogenicity Associates With Major Adverse Cardiovascular Events; Insights From Intravascular Ultrasound.. In CIRCULATION Vol. 138 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS.
2017 Honda, S., Kataoka, Y., Shishikura, D., Takata, K., Andrew, J., Butters, J., . . . Nicholls, S. J. (2017). Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 117-118). Barcelona, SPAIN: OXFORD UNIV PRESS.
2017 Takata, K., Honda, S., Sidharta, S., Duong, M., Shishikura, D., Kim, S., . . . Nicholls, S. J. (2017). Association between cholesterol efflux capacity and coronary plaque lipid composition on near infrared spectroscopy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 467). OXFORD UNIV PRESS.
2017 Shishikura, D. S., Kataoka, Y. K., Honda, S. H., Takata, K. T., Kim, S. K., Andrews, J. A., . . . Nicholls, S. J. N. (2017). The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 232). SPAIN, Barcelona: OXFORD UNIV PRESS.
2016 Munnur, R. K., McCormick, L., Ko, B., Psaltis, P., Cameron, J., Meredith, I., . . . Wong, D. (2016). DIAGNOSTIC ACCURACY OF ASLA SCORE (A NOVEL CT ANGIOGRAPHIC INDEX) AND AGGREGATE PLAQUE VOLUME IN THE ASSESSMENT OF FUNCTIONAL SIGNIFICANCE OF CORONARY STENOSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 1673). IL, Chicago: ELSEVIER SCIENCE INC.
DOI
2016 Raphael, C. E., Spoon, D., Bell, M., Psaltis, P. J., Kidd, S., Loh, S. X., . . . Gulati, R. (2016). IMPACT OF THROMBOCYTOPENIA ON PROGNOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 185). IL, Chicago: ELSEVIER SCIENCE INC.
DOI
2014 Nerlekar, N., Nasis, A., Ko, B., Leung, M., Cameron, J., Wong, D., . . . Seneviratne, S. (2014). IMPACT OF HEART RATE ON DIAGNOSTIC ACCURACY OF SECOND GENERATION 320-DETECTOR COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1051). ELSEVIER SCIENCE INC.
DOI
2013 Spoon, D. B., Psaltis, P. J., Singh, M., Holmes, D. R., Gersh, B. K., Rihal, C. S., . . . Gulati, R. (2013). Trends in Cause of Long-Term Death After Percutaneous Coronary Intervention. In CIRCULATION Vol. 128 (pp. 1 page). TX, Dallas: LIPPINCOTT WILLIAMS & WILKINS.
WoS1
2013 Spoon, D. B., Psaltis, P. J., Kidd, S., Prasad, A., Lennon, R., Singh, M., & Gulati, R. (2013). OUTCOMES AFTER PCI IN PATIENTS WITH THROMBOCYTOPENIA. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 61 (pp. E1718). CA, San Francisco: ELSEVIER SCIENCE INC.
DOI
2013 Spoon, D. B., Psaltis, P. J., Holmes, D., Simari, R., Gersh, B., Lennon, R., . . . Gulati, R. (2013). TEMPORAL TRENDS IN THE CAUSE OF LONG-TERM DEATH AFTER PCI: A 20-YEAR SINGLE-CENTER EXPERIENCE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 61 (pp. E1590). CA, San Francisco: ELSEVIER SCIENCE INC.
DOI
2012 Spoon, D. B., Psaltis, P. J., Hoffman, S. J., Witt, T. A., Lerman, A., Khosla, S., & Simari, R. D. (2012). Delivery of Osteocalcin (OCN plus ) Expressing Myeloid Cells is Sufficient to Generate Vascular Calcification. In CIRCULATION Vol. 126 (pp. 1 page). LIPPINCOTT WILLIAMS & WILKINS.
2011 Psaltis, P. J., Peterson, K., Xu, R., Franchi, F., Chen, I. Y., Simari, R. D., . . . Rodriguez-Porcel, M. G. (2011). In vivo Imaging of Oxidative Stress in Mesenchymal Stromal Cells Transplanted After Myocardial Ischemia/Reperfusion Injury. In CIRCULATION Vol. 124 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS.
2011 Psaltis, P. J., Harbuzariu, A., Delacroix, S., Witt, T., Kleppe, L., Mueske, C., . . . Simari, R. D. (2011). Sca-1 Identifies a Monocyte-Predisposed Hierarchy of Hematopoietic Progenitor Cells in the Postnatal Murine Aorta. In CIRCULATION Vol. 124 (pp. 1 page). LIPPINCOTT WILLIAMS & WILKINS.
2010 Lau, D. H., Carbone, A., Psaltis, P. J., Mackenzie, L., Metcalf, R., Kuklik, P., . . . Sanders, P. (2010). ATRIAL PROTECTIVE EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS: A LONG TERM STUDY IN OVINE CHRONIC HEART FAILURE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 55 (pp. 1 page). ELSEVIER SCIENCE INC.
2010 Delacroix, S., Boylan, B. J., Harbuzariu, A., Psaltis, P. J., Pan, S., Holroyd, E., . . . Simari, R. D. (2010). NPR-B Expression In Megakaryocytes and Platelets.. In BLOOD Vol. 116 (pp. 1751-1752). FL, Orlando: AMER SOC HEMATOLOGY.
2010 Harbuzariu, A., Psaltis, P. J., Witt, T. A., Kleppe, L. S., Delacroix, S., Holroyd, E. W., . . . Simari, R. D. (2010). Bone Marrow Mononuclear Cells Contribute to the Vascular Hematopoietic Niche. In CIRCULATION Vol. 122 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS.
2009 Psaltis, P. J., Carbone, A., Manavis, J., Jantzen, T., Lau, D., Sanders, P., . . . Worthley, S. G. (2009). Catheter-based Electromechanical Mapping Accurately Characterizes Segmental Distribution of Left Ventricular Fibrosis in Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S906). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
2009 Psaltis, P. J., Zannettino, A., Carbone, A., Manavis, J., Williams, K., Jantzen, T., . . . Worthley, S. G. (2009). Cardiac Repair With Transendocardial Injection of Allogeneic Mesenchymal Precursor Cells for Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S827). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
2009 Psaltis, P. J., Worthley, S. G., See, F., Itescu, S., Martens, T., Gronthos, S., & Zannettino, A. (2009). Enrichment for Stro-1 Enhances Paracine-mediated Cardiovascular Repair From Human Bone Marrow Mesenchymal Cells. In CIRCULATION Vol. 120 (pp. S821). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
2007 See, F., Seki, T., Psaltis, P., Martens, T., Gronthos, S., Worthley, S., . . . Itescu, S. (2007). Human stroll mesenchymal precursor cells induce proliferative effects on vascular smooth muscle cells and endothelium via P13 kinase dependent pathways. In CIRCULATION Vol. 116 (pp. 104). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
2004 Roberts-Thomson, K. C., Psaltis, P. J., Kee, P., & Young, G. D. (2004). Long term follow up of patients undergoing electrophysiological study on amiodarone. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY Vol. 37 (pp. 264). Brisbane, AUSTRALIA: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.

Year Citation
2025 Mahadevan, J. J., Jannes, J., Psaltis, P. J., Thrift, A. G., & Kleinig, T. J. (2025). Adelaide Stroke Incidence Study 2: Stroke incidence and mortality declining despite population aging. Poster session presented at the meeting of CEREBROVASCULAR DISEASES. KARGER.
2024 Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2024). Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press.
DOI WoS1
2022 Nankivell, V. A., Vidanapathirana, A., Rajora, M., Psaltis, P., Tan, J. T., Tieu, W., . . . Bursill, C. A. (2022). Theranostic Properties of Porphysome Nanoparticles in Atherosclerotic Cardiovascular Disease. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
WoS2
2022 Primer, K. R., Tan, J. T., Psaltis, P. J., & Bursill, C. A. (2022). Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
2022 Pullen, B. J., Vidanapathirana, A. K., Sandeman, L., Everest-Dass, A., Kolarich, D., Tan, J. T., . . . Bursill, C. A. (2022). Deletion of the Asialyloglycoprotein Receptor-1 Causes Athero-Protective Effects in vitro and in vivo. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
WoS2
2022 Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., . . . Verjans, J. W. (2022). Cardiovascular disease risk prediction via machine learning using mental health data. Poster session presented at the meeting of Abstracts of the European Society of Cardiology (ESC 2002), as published in European Heart Journal. Barcelona, Spain: Oxford University Press.
DOI WoS2
2019 Akers, E. J., Mulangala, J., Wilsdon, L. A., Psaltis, P. J., Bursill, C. A., Nicholls, S. J., & Di Bartolo, B. A. (2019). Lipoproteins and Their Modified Forms Regulate Early Stage Vascular Smooth Muscle Cell Calcification. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Boston, MA: LIPPINCOTT WILLIAMS & WILKINS.
2019 Opperman, K., Vandyke, K., Psaltis, P., Croucher, P., Noll, J., & Zannettino, A. (2019). Macrophages as a potential therapeutic target: Clodronate-liposome treatment inhibits multiple myeloma tumour establishment in vivo. Poster session presented at the meeting of CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. CIG MEDIA GROUP, LP.
DOI
2019 Solly, E., Hourigan, S. T., Mulangala, J., Psaltis, P. J., Di Bartolo, B., Martin, N., . . . Tan, J. T. M. (2019). Inhibition of miR-181c Rescues Diabetes-Impaired Angiogenesis. Poster session presented at the meeting of DIABETES. CA, San Francisco: AMER DIABETES ASSOC.
DOI
2019 Williamson, A., Toledo, D. F., Schwarz, N., Fernando, S., Dimasi, C., Liyanage, S., . . . Psaltis, P. J. (2019). Postnatal mouse aorta contains yolk sac-derived haemangioblasts with myeloid and endothelial plasticity and vasculogenic capacity. Poster session presented at the meeting of European Heart Journal. Paris, France: Oxford University Press.
2019 Franke, K., Marshall, H., Worthley, M., & Psaltis, P. J. (2019). A systematic review and meta-analysis on spontaneous coronary artery dissection: epidemiology, risk factors and outcomes. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS.
2019 Fernando, S., Schwarz, N., Sandeman, L., Skoumbourdis, T., Zareh, J., Williamson, A., . . . Psaltis, P. J. (2019). Eukaryotic Elongation Factor 2 Kinase Regulates Cholesterol Uptake by Macrophages via Cd36 Scavenger Receptor Expression. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS.
2019 Wong, N. K., Solly, E., Nicholls, S., Psaltis, P., Ng, M. K., Bursill, C. A., & Tan, J. T. (2019). <i>TRIM2</i> an<i>d CREBRF</i> Are Novel Regulators of Angiogenic Functions in Human Coronary Artery Endothelial Cells. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS.
2018 Takata, K., Duong, M., Honda, S., Sidharta, S. L., Kim, S. W., Shishikura, D., . . . Nicholls, S. J. (2018). Association of Apolipoprotein C-III Distribution With Cholesterol Efflux Capacity and Coronary Plaque Burden. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.
2017 Pisaniello, A., Di Bartolo, B., Liu, G., Gibson, R., Kim, S., Psaltis, P., & Nicholls, S. (2017). THE IMPACT OF ORAL OMEGA-3 FATTY ACID SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN A MOUSE MODEL. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI WoS1
2017 Takata, K., Duong, M., Kim, S., Di Bartolo, B., Butters, J., Mani, P., . . . Nicholls, S. J. (2017). GREATER CIRCULATING CONCENTRATIONS OF LARGE HDL PARTICLES ASSOCIATE WITH MORE FAVORABLE HDL FUNCTIONALITY IN YOUNG ADULTS. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI
2017 Shishikura, D., Sidharta, S. L., Honda, S., Takata, K., Kim, S., Andrews, J., . . . Nicholls, S. J. (2017). THE RELATIONSHIP BETWEEN SEGMENTAL WALL SHEAR STRESS AND NIRS-DERIVED LIPID CORE PLAQUE. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI
2017 Mulangala, J., Akers, E. J., Psaltis, P. J., Nicholls, S. J., & Di Bartolo, B. A. (2017). Calcium Dose Dependently Influences Endothelial Cell Angiogenesis. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Minneapolis, MN: LIPPINCOTT WILLIAMS & WILKINS.
2017 Honda, S., Sidharta, S., Shishikura, D., Takata, K., Andrews, J., Kim, S., . . . Nicholls, S. (2017). GENDER RELATED DIFFERENCES OF SERIAL CHANGE IN CORONARY PLAQUE COMPOSITION. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI
2017 Honda, S., Sidharta, S., Shishikura, D., Takata, K., Andrews, J., Kim, S., . . . Nicholls, S. (2017). HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AS A DETERMINANT OF CHANGE IN CORONARY PLAQUE LIPID BURDEN ASSESSED BY NEAR INFRARED SPECTROSCOPY. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI
2016 Pullen, B., Nguyen, T., Gosnell, M., Anwer, A., Goldys, E., Nicholls, S., & Psaltis, P. (2016). Label-free assessment of endothelial cell metabolic state using autofluorescent microscopy. Poster session presented at the meeting of Proceedings of SPIE - The International Society for Optical Engineering. SPIE.
DOI
2009 Lau, D. H., Mackenzie, L., Kelly, D. J., Psaltis, P. J., Worthington, M., Rajendram, A., . . . Sanders, P. (2009). Hypertension and atrial fibrillation: a long term study of remodeling in a conscious ovine model. Poster session presented at the meeting of Abstracts of the 82nd Scientific Session of the American Heart Association, as published in Circulation. Orlando, FL: American Heart Association.

Year Citation
2026 Seeley, M. -C., Tran, D. X. A., Marathe, J., Sharma, S., Wilson, G., Atkins, S., . . . Psaltis, P. (2026). Antecedent autonomic symptoms predict contemporary autonomic symptom burden and reduced health-related quality of life after spontaneous coronary artery dissection.
DOI
2025 Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis.
DOI
2024 Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A., Rajora, M., Chen, J., . . . Bursill, C. (2024). Multifunctional biomimetic porphyrin-lipid nanoparticles – novel nanoscale theranostics for atherosclerotic cardiovascular disease.
DOI
2024 Freidoonimehr, N., Atkins, T., Marathe, J. A., Psaltis, P. J., & Arjomandi, M. (2024). Evaluating the severity of tandem coronary stenoses: Insights from
simulated FFR and iFR techniques.
2024 Ruchka, P., Kushwaha, A., Marathe, J. A., Xiang, L., Chen, R., Kirk, R., . . . Li, J. (2024). 3D-printed axicon enables extended depth-of-focus intravascular optical
coherence tomography.
2024 Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V., Stretton, L. G., Solly, E., . . . Bursill, C. (2024). Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia.
DOI
2026-31 National Health and Medical Research Council of Australia, Centres of Research Excellence (ID:2026/GNT2054843)

Peter James Psaltis (CIB)

Title: Centre for Research Excellence to Detect and Treat Silent Coronary Artery Disease.

 $3,000,000.
2026-28 Medical Research Future Fund. (ID:2026/MRF2054345)

Peter James Psaltis (CI)

Title: Novel biomarkers of atherosclerotic cardiovascular disease in diabetes: the Asialoglycoprotein Receptor 1 and the glycome.

 $926,815.10
2026-29 National Health and Medical Research Council of Australia, Ideas Grant (ID:2025/GNT2046944)

Peter James Psaltis (AI)

Title: Novel atheroprotective properties of Diroximel Fumarate 

 $1,262,404.43
2026-30 Medical Research Future Fund, Early to Mid-Career Researchers (ID:2037779)

Peter James Psaltis (AI)

Title: Personalised cardiovascular risk assessment nano-tools for older people experiencing diseases of ageing: nanotechnology to transform clinical cardiology. 

 $4,239,608.53
2025-27 CALHN CEO Clinical Rapid Implementation Project Scheme Grant

Peter James Psaltis (Lead Researcher)

Title: Systematic lipid profiling and therapy optimisation in vascular surgical patients with Very High-Risk atherosclerotic disease.

 $200,000
2025-27 Heart Foundation Catalyst Partnership Grant (ID108710-2024_CPG). 

Peter James Psaltis (CIB)

Title: Hybrid 3D-printed imaging device for precision heart care. 

 $100,000
2025-27 Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease

Peter James Psaltis (CIB)

Title: Hybrid 3D-printed intravascular imaging device for accurate detection of high-risk coronary artery disease. 

 Tranche A Investment $1,000,000
2024-27 Partnership Projects PRC3 (ID 2044775)

Peter James Psaltis (CID)

Title: Developing an evidence-based clinical pathway for reducing coronary artery disease risks related to per- and polyfluoroalkyl substances (PFAS) in firefighters and communities with high exposure levels.

 $3,741, 231
2024-27 National Health and Medical Research Council of Australia, Ideas Grant (ID2028599)

Peter James Psaltis (Associate Investigator)

Title: Predicting delirium vulnerability from pre-surgery neurophysiological measures. 

 $1,215,441
2024-27 National Health and Medical Research Council of Australia, Ideas Grant (ID2029177)

Peter James Psaltis (Associate Investigator)

Title: Inhibition of asialoglycoprotein receptor 1: a novel strategy for atherosclerosis prevention. 

 $1,184,728
2024 Adelaide Medical School, The University of Adelaide, Mature Grant Development Award  Peter James Psaltis $62,972
2023-27 National Health and Medical Research Council of Australia, Medical Research Future Fund

Peter James Psaltis (CIG)

Title: Towards a culturally appropriate coordination, rehabilitation and secondary prevention model in primary care for Aboriginal people hospitalised with chronic disease. 

 $2,388,524.70
2023-26 National Heart Foundation of Australia, Level 3 Future Leaders Fellowship (ID106656) 

Peter James Psaltis (CIA)

Title: Defining a new player in atherosclerosis: The role of Adventitial Endothelial-Macrophage Progenitor Cells as an “outside-in” driver of plaque growth and stability. 

 $693,200

2023-26 National Health and Medical Research Council of Australia, Development Grant (ID GNT2022337)

Peter James Psaltis (CIB) 

Title: Hybrid 3D-printed imaging catheter for more accurate cardiovascular disease detection.

 $985,058.50
2023-25 The Hospital Research Foundation Innovations in Disease Diagnostics Grant (ID 2022-CP-IDMH-014-83100)

Peter James Psaltis (CIB) 

Title: More accurate detection of heart disease in patients using the world's smallest 3D-printed imaging catheter.  

 $250,000

2023-25 The Hospital Research Foundation (ID 2022-CP-Heart-010-83100)

Peter James Psaltis (CIA)

Title: The “Can SeMaglutide Achieve Stabilisation of coronary atHerosclerosis after Myocardial Infarction (SMASH-MI)” study.

 $250,000

2022-25 National Health and Medical Research Council of Australia (MRF2016053)

Peter James Psaltis (CIB) 

Title: The Asialoglycoprotein Receptor 1 (ASGR1): a novel target for atherosclerosis. 

 $999,989.20

2022-25 National Health and Medical Research Council of Australia (MRF2016221)

Peter James Psaltis (Associate Investigator)

Title: Atheroma Progression in Clonal Haematopoiesis Investigation with Imaging, Biomarkers and Genomic Sequencing (ARCHIMEDES) .

 $996,384.68
2022-24 National Health and Medical Research Council of Australia, Ideas Grant (ID2010804)

Peter James Psaltis (Associate Investigator)

Title: Measuring healthy ageing: finding an autophagy biomarker for a scalable clinical test. 

 $818,964.40

2022-24 The Hospital Research Foundation (ID 2022-CP-Heart-023) 

Peter James Psaltis (Associate Investigator)

Title: Biomechanical stress profiling of coronary atherosclerosis: Towards predicting plaque progression. 

 $250,000
2022 Vascular Foundation Grant

Peter James Psaltis (CIB)

Title: Evaluation of a novel blood-based biomarker to measure autophagy as a driver of atherosclerotic peripheral artery disease. 

 $30,000
2022 Channel 7 Children’s Research Foundation (ID 20658466)

Peter James Psaltis (CIB)

Title: Human umbilical cord-derived haemangioblasts: discovery of a robust stem cell population for skin wound healing in children. 

 $40,000
2020-25 National Health and Medical Research Council of Australia, Centres of Research Excellence (ID1196629)

Peter James Psaltis (CIH)

Title: NHMRC Centre of Research Excellence for Better Outcomes in Coronary Artery Disease. 

 $2,500,000
2021-22 The Hospital Research Foundation Translational Grant (ID C-PJ-004_Transl-2020)

Peter James Psaltis (CIB)

Title: World’s smallest 3D-printed imaging catheter to identify patients at high risk for myocardial infarction and optimise treatments.

 $70,000
2021-23 National Health and Medical Research Council of Australia, Ideas Grant (ID2001541)

Peter James Psaltis (CIA)

Title: Defining a new player in atherosclerosis: The role of Adventitial Haemangioblasts as an "outside-in" driver of plaque growth and stability.

** Winner of Marshall Warren Innovation Award.

 $728,004.50
2021-24 National Health and Medical Research Council of Australia, Ideas Grant (ID2001646)

Peter James Psaltis (Associate Investigator)

Title: Serial imaging of molecular and microstructural changes in atherosclerosis: tracking plaques towards destabilisation.

 $992,112
2020-2021 National Heart Foundation of Australia, Vanguard Grant (ID102981)

Peter James Psaltis (CIA)

Title: What role do local stem cells play in atherosclerosis?

 $140,000
2020-2022  National Health and Medical Research Council of Australia, Development Grant (ID1175142)

Peter James Psaltis (CIC)

Title: Bioinvisible stents – a new device coating to repair cardiovascular disease.

 $671,960
2020-2024 National Health and Medical Research Council of Australia, Clinical Trials and Cohort Studies (ID1187193) 

Peter James Psaltis (CIJ)

Title: COLchicine CARDIovascular Outcomes in Acute Coronary Syndrome (COLCARDIO-ACS) Study.

 $4,238,895.50
2020-2023 National Health and Medical Research Council of Australia, MRFF (ID1201375)

Peter James Psaltis (Associate Investigator)

Title:  Using Polygenic Risk Scores to Target Statin Therapy in Primary Prevention.

 $1,400,000
2020-2023 National Health and Medical Research Council of Australia, Ideas Grant (ID1184571)

Peter James Psaltis (Associate Investigator)

Title: Novel nanoscale theranostic applications of porphysomes in atherosclerotic cardiovascular disease. 

 $632,690
2020 South Australian Health and Medical Research Institute, seed funding.

Peter James Psaltis (CIB)

Title: Finding disease drivers for atherosclerosis: measurement of autophagic flux in a human cohort.

 $30,000
2019-2022 National Health and Medical Research Council of Australia, Level 2 Career Development Fellowship (ID1161506) 

Peter James Psaltis (CIA)

Title: New approaches to target plaque inflammation in atherosclerosis.

 $386,724
2019-2022 National Heart Foundation of Australia, Level 2 Future Leaders Fellowship (ID102056) 

Peter James Psaltis (CIA)

Title: New approaches to target plaque inflammation in atherosclerosis.

 $200,000
2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1142794)

Peter James Psaltis (CIA)

Title: The novel role of Eukaryotic Elongation Factor 2 Kinase (eEF2K) in atherosclerosis.

 $650,531
2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1140996)

Peter James Psaltis (CIC)

Title: Bone marrow macrophages: “Resident Evil” in the establishment and progression of multiple myeloma.

 $570,585
2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1138917)

Peter James Psaltis (Associate Investigator)

Title: Role for zinc and ZIP2 in the action of nitric oxide and in vascular protection against cigarette smoke and cardiovascular disease. 

 $685,940.60
2018 Sylvia and Charles Viertel Charitable Foundation Clinical Investigator Award (VIERCI2017016)

Peter James Psaltis (CIA)

Title: Colchicine for coronary plaque modification in acute coronary syndrome. 

 $85,000
2018 Royal Australasian College of Physicians, Career Development Fellowship

Peter James Psaltis (CIA)

Title: A Novel Role for Adventital Macrophage Progenitor Cells (AMPCs) in providing a local source of macrophages in atherosclerosis. 

 $100,000
2018 National Heart Foundation of Australia, Tom Simpson Trust Fund

Peter James Psaltis (CIA)

 

 $16,500
2018 Foundation for Children. Project (ID 289)

Peter James Psaltis (CIC)

Title: Improving the long-term cardio-metabolic health of preterm infants through nutritional interventions: A role for omega-3 fatty acids?

 $124,550
2017-2020 NHMRC Project Grant (ID 1127159)

Peter James Psaltis (CIA)

Title: A study of the plaque - modifying actions of colchicine in stable and unstable atherosclerosis: from mouse models to clinical imaging

 $1,198,460
2017 National Heart Foundation of Australia, Vanguard Project Grant (ID 101370)

Peter James Psaltis (CIA)

Title: Colchicine for coronary plaque modification in acute coronary syndrome - A serial optical coherence tomography study

 $75,000
2017 National Heart Foundation of Australia, Tom Simpson Trust Fund Peter James Psaltis (CIA) $9,150
2017 Abbott Vascular Pty Ltd, Research Grant Peter James Psaltis (CIA) $10,000
2016 5th International Congress on Lipid Metabolism and Atherosclerosis, Travel Grant Peter James Psaltis $1,500
2015-2017 NHMRC Project Grant (ID 1086796)

Peter James Psaltis (CIA)

Title: A study of the origins of macrophages in healthy and atherosclerotic vasculature focusing on a novel population of resident adventitial macrophage progenitor cells (AMPCs)

 $451,125.50
2015-2018 National Heart Foundation of Australia, Future Leadership Fellowship (FLF100412)

Peter James Psaltis (CIA)

Title: Investigating the development of macrophages in atherosclerosis through a novel pathway of resident adventitial macrophage progenitor cells

 $412,000.00
2014-2020 ARC Centre of Excellence

Peter James Psaltis (Associate Investigator)

Centre for Nanoscale Biophotonics

 $23,000,000
2010-2014 NHMRC Post-doctoral Overseas Biomedical Fellowship (ID 0627055)

Peter James Psaltis (CIA)

Title: The myelopoietic potential of vascular adventitial progenitor cells (APCs) and their role in atherosclerosis

 $369,519
2010 Royal Australasian College of Physicians, Marjorie Hooper Overseas Fellowship Peter James Psaltis $20,000
2006-2009 NHMRC (co-funded), Post-graduate Biomedical Scholarship

Peter James Psaltis

Title: A study of the properties of STRO-1 selected mesenchymal stem cells and their potential for cardiac repair

 $110,385
Date Position Institution Name
2024 -  Level E, Clinical Academic, Faculty of Health and Medical Sciences, Adelaide Medical School University of Adelaide 
2019 - 24 Level D, Clinical Academic, Faculty of Health and Medical Sciences, Adelaide Medical School University of Adelaide
2015 - 18 Level C, Clinical Academic University of Adelaide
2004 - 14 Senior Lecturer, School of Medicine University of Adelaide

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor The role of biomechanical forces in coronary atherosclerosis progression after myocardial infarction. Doctor of Philosophy Doctorate Part Time Dr Alex Binnie
2025 Principal Supervisor REFORM CVD: RE-Focusing on Obesity as a Risk Factor to Manage in Cardiovascular Disease Master of Philosophy (Clinical Science) Master Part Time Mr Matthew Yi-Wei Lim
2025 Principal Supervisor The role of intracoronary biomechanical forces in the natural history of coronary artery disease Doctor of Philosophy Doctorate Part Time Dr Alex Binnie
2025 Principal Supervisor Exploring novel approaches to residual inflammation in coronary artery disease Doctor of Philosophy Doctorate Full Time Dr Rajesh Pathy
2025 Principal Supervisor Novel INfluential Factors in the natural histOry of Non-Obstructive Coronary Artery disease syndrome (INFO-NOCA) study Doctor of Philosophy Doctorate Full Time Ms Alex Tran
2025 Principal Supervisor Predictors of recurrent ischaemic events post myocardial infarction in people with type 2 diabetes mellitus Doctor of Philosophy Doctorate Part Time Miss Momina Ahmed Allahwala
2024 Co-Supervisor Continuous imaging of molecular and microstructural changes in atherosclerosis by a 3d-printed multimodal endoscope Doctor of Philosophy Doctorate Full Time Miss Yujia Kong
2024 Principal Supervisor Predictors of recurrent ischaemic events post myocardial infarction in patients with type 2 diabetes mellitus - Master Full Time Miss Momina Ahmed Allahwala
2024 Co-Supervisor Improved classification of cardiovascular plaques in intravascular imaging using deep learning. Doctor of Philosophy Doctorate Full Time Mr Yi Chen
2024 Principal Supervisor The role of coding and non-coding RNA in atherosclerotic plaque phenotype in diabetic vs non-diabetic patients with peripheral arterial disease Doctor of Philosophy Doctorate Part Time Dr Benjamin Thurston
2023 Co-Supervisor Biomechanical Analysis of Diseased Coronary Arteries Doctor of Philosophy Doctorate Full Time Mr Yaofeng Ju
2023 Principal Supervisor New Predictive Factors that Drive Coronary Artery Disease Doctor of Philosophy Doctorate Full Time Miss Naomi Elizabeth Wattchow
2023 Co-Supervisor The role of the asialoglycoprotein receptor-1 in immune cell regulation of atherosclerosis Doctor of Philosophy Doctorate Full Time Mr Demeke Geremew Debebe
2022 Principal Supervisor The Evaluation and Validation of Autophagy as a Novel Biomarker of Coronary Artery Disease Doctor of Philosophy Doctorate Part Time Dr Mau Tam Nguyen
2021 Principal Supervisor Population Based Studies of Stroke Incidence, Subtypes, Treatments and Outcomes in South Australia Doctor of Philosophy Doctorate Part Time Mr Joshua Mahadevan

Date Role Research Topic Program Degree Type Student Load Student Name
2020 - 2024 Co-Supervisor Nonlinear Biomechanics of Aortic System Doctor of Philosophy Doctorate Full Time Ms Xiaochen Wang
2019 - 2024 Principal Supervisor Applications of Clinical Lipidomics to Metabolic Diseases: Methodology and Implications Doctor of Philosophy Doctorate Full Time Mr Jake White
2019 - 2023 Co-Supervisor Fluid-Structure Interaction for Heart Attack Prediction Doctor of Philosophy Doctorate Full Time Mr Harry James Carpenter
2019 - 2023 Principal Supervisor Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Ms Sanuri Rashmitha Liyanage
2018 - 2022 Principal Supervisor Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Miss Anna Emilie Williamson
2018 - 2019 Co-Supervisor Plaque Rupture Prediction in Human Arteries Doctor of Philosophy Doctorate Full Time Dr Alireza Gholipour
2017 - 2020 Co-Supervisor Control of adipocyte differentiation and metabolism by mitogen-activated protein kinase (MAPK)-interacting kinases (MNKs) Doctor of Philosophy Doctorate Full Time Mr James Edward Merrett
2017 - 2021 Co-Supervisor Macrophages, Myeloma, Mouse Models and Methodologies Doctor of Philosophy Doctorate Full Time Mrs Khatora Shanae Opperman
2017 - 2021 Principal Supervisor Molecular Mediators of Macrophage Foam Cell Formation and Atherosclerosis and their Pharmacological Modification Doctor of Philosophy Doctorate Full Time Ms Sanuja Fernando
2016 - 2022 Co-Supervisor OPTIMISATION OF SURGICAL TIMING IN RHEUMATIC MITRAL VALVE
DISEASE		 Doctor of Philosophy Doctorate Full Time APrf Ross Roberts-Thomson
2015 - 2020 Co-Supervisor Triglyceride Rich Lipoproteins and Apolipoprotein C-III in Atherosclerosis Doctor of Philosophy Doctorate Full Time Miss Wenru Pan
2008 - 2011 Co-Supervisor The Effects of Omega-3 Fatty Acids in an Ovine Model of Anthracycline-induced Non-ischaemic Cardiomyopathy Master of Medical Science Master Full Time Mr Angelo Carbone

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2025 - ongoing External Supervisor PhD Candidate University of Sydney - Doctorate - Dr Daniel Brieger
2024 - 2024 Co-Supervisor Honours Student Flinders University - Honours - Mr Jiyon Ju
2023 - ongoing Co-Supervisor PhD Candidate Flinders University - Doctorate - Dr Bronwyn Beelders
2023 - ongoing Principal Supervisor Masters Candidate University of Adelaide - Master - Dr Shabman Torabiardakani
2023 - 2023 Principal Supervisor Honours Student University of Adelaide - Honours - Ms Sylvia Kulesza
2022 - ongoing Co-Supervisor PhD Candidate University of Sydney - Doctorate - Ms Pich Chhay,
2021 - 2022 Principal Supervisor Honours Student (1st class Honours, scored 95%, top mark in Faculty) University of Adelaide - Honours - Ms Dang Xuan Anh Tran
2021 - 2021 Principal Supervisor Honours Student (1st class Honours) University of Adelaide - Honours - Ms Pich Chhay
2021 - 2021 Principal Supervisor Honours Student (1st class Honours) University of Adelaide - Honours - Ms Helia Abdohali
2019 - 2019 Principal Supervisor Honours Student (scored 95%, top ranked) University of Adelaide - Honours - Dr Aaron Long
2019 - 2019 Principal Supervisor Honours Student (scored 90%) University of Adelaide - Honours - Esma Kararmaz
2018 - 2018 Principal Supervisor Honours Student (scored 90%) University of Adelaide - Honours - Sanuri Liyanage
2018 - 2018 Co-Supervisor Honours Student University of Adelaide - Honours - Jake White
2017 - 2021 Co-Supervisor PhD Candidate University of South Australia - Doctorate - Ms Danielle Ann Greaves
2017 - 2018 Co-Supervisor PhD Candidate University of South Australia - Doctorate - Ms Erica Chung Tilley
2016 - 2016 Principal Supervisor Honours Student Awarded Class IA Honours (scored 89%) University of Adelaide - Honours - Sanuja Fernando
2016 - 2016 Principal Supervisor Honours Student Awarded Class IA Honours (scored 88%) University of Adelaide - Honours - Anna Williamson
2016 - 2016 Principal Supervisor Honours Student Awarded Class IA Honours (scored 88%) University of Adelaide - Honours - Jonar Zareh
2015 - 2020 Co-Supervisor PhD Student University of Adelaide - Doctorate - Daniel Scherer
2015 - 2018 Co-Supervisor Doctor of Medicine Monash University - Doctorate - Dr Vimal Boganashanmugan

Date Topic Location Name
2024 - ongoing Principal Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Marie-Claire Seeley
2024 - ongoing Co-Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Oscar Zi Shao Ong
2023 - ongoing Principal Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Sanuri Liyanage
2023 - ongoing Principal Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Harry Carpenter
2022 - ongoing Principal Supervisor - Senior Postdoctoral Research Fellow Vascular Research Centre, SAHMRI Dr Shiwani Sharma
2022 - ongoing Principal Supervisor - Senior Clinician Scientist Vascular Research Centre, SAHMRI Dr Jessica Marathe
2020 - 2022 Principal Supervisor - Post-doctoral Fellow University of Adelaide Dr Mohammadhossein Hassanshahi
2017 - 2018 Principal Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Thao Nguyen
2015 - 2019 Principal Supervisor - Postdoctoral Research Fellow University of Adelaide Dr Nisha Schwarz
2015 - 2018 Principal Supervisor - Postdoctoral Research Fellow Heart Health Theme, SAHMRI Dr Deborah Toledo-Flores

Date Role Board name Institution name Country
2026 - ongoing Advisory Board Member Scientific Advisory Committee Vysena Medical Australia
2024 - ongoing Member Board Corcillum Systems Pty Ltd Australia
2024 - ongoing Member Board Australian Cardiovascular Alliance (ACvA) Australia
2018 - 2021 Member Board South Australian Postgraduate Medical Education Association (SAPMEA) Australia

Date Role Committee Institution Country
2025 - ongoing Member Public Officer The Australian Atherosclerosis Society Incorporated Australia
2025 - ongoing Member Patron Heart Support Australia Australia
2025 - ongoing Member Executive, Philanthropy Committee South Australian Health and Medical Research Institute (SAHMRI) Australia
2024 - ongoing Co-Chair Co-Chair, Coronary Artery Disease Clinical Theme Australian Cardiovascular Alliance Australia
2023 - ongoing Member Member, Peripheral Artery Disease Clinical Theme Australian Cardiovascular Alliance Australia
2023 - ongoing Member National Coordinator, SURMOUNT-MMO multinational clinical trial (Eli Lilly) Eli Lilly Australia
2023 - ongoing Co-Chair SA Cardiovascular Research Network Executive Committee Heart Foundation Australia
2023 - 2024 Member Executive Group Member Adelaide Health Innovation Partnership Australia
2023 - ongoing Co-Chair SA Cardiovascular Research Network Executive Committee Heart Foundation Australia
2022 - ongoing Co-Chair Heart and Stroke Leadership Group South Australian Aboriginal Chronic Disease Consortium Australia
2020 - ongoing Member Steering Committee NHMRC-funded COLCARDIO-ACS study Australia
2020 - ongoing Member Steering Committee NHMRC-funded Da Vinci study Australia
2020 - 2024 Member Scientific Committee Cardiac Society of Australia and New Zealand Australia
2020 - 2021 President President Australian Atherosclerosis Society Australia
2019 - ongoing Member Leadership Executive Committee, Lifelong Health Theme South Australian Health and Medical Research Institute (SAHMRI) Australia
2019 - 2020 Chair Scientific Program Chair Cardiac Society of Australia and New Zealand Australia
2018 - ongoing Member Executive Committee Australian Atherosclerosis Society Australia
2017 - 2024 Member Principal Investigator, COCOMO-ACS trial NHMRC Australia
2017 - 2022 Member Imaging Core Laboratory Head, multinational HUYGENS study AMGEN Australia
2017 - ongoing Member Clinical Council Australian Atherosclerosis Society Australia
2017 - ongoing Member Grant Review Panel National Health and Medical Research Council Australia
2016 - ongoing Member Reconciliation Action Plan (RAP) Committee South Australian Health and Medical Research Institute (SAHMRI) Australia
2016 - ongoing Member Research Executive Committee South Australian Health and Medical Research Institute (SAHMRI) Australia
2016 - ongoing Member Acute Coronary Syndrome Task Force SA Health Australia
2016 - ongoing Member Research Executive Committee South Australian Health and Medical Research Institute (SAHMRI) Australia
2015 - ongoing Member Bioscience Pillar Committee Member South Australian Health and Medical Research Institute (SAHMRI) Australia
2015 - 2016 Member Scientific Program Committee and Interventional Stream Leader, 64th Annual Scientific Meeting Cardiac Society of Australia and New Zealand Australia

Date Role Membership Country
2025 - ongoing Member Australian Atherosclerosis Society, Life member Australia
2018 - ongoing Member American College of Cardiology United States
2018 - ongoing Member Australian Vascular Biology Society Australia
2017 - ongoing Member Australian Atherosclerosis Society Australia
2016 - ongoing Member Cardiac Society of Australia and New Zealand (Fellow) Australia
2016 - ongoing Member Australian Cardiovascular Alliance Australia
2016 - ongoing Member Acute Coronary Syndrome Task Force, SA Health Australia
2014 - ongoing Member International Society for Heart Research Australia
2011 - ongoing Member American Heart Association, Councils of Basic Cardiovascular Sciences and Arteriosclerosis, Thrombosis and Vascular Biology United States
2009 - ongoing Member Australian Society of Medical Research Australia
2009 - ongoing Member International Society of Heart Research Australia
2005 - ongoing Member Royal Australasian College of Physicians (Fellow) Australia
2004 - ongoing Member Cardiac Society of Australia and New Zealand (Fellow) Australia

Date Role Editorial Board Name Institution Country
2025 - ongoing Associate Editor European Journal of Preventive Cardiology - United Kingdom
2025 - ongoing Editor Special Issue Editor - Cardiovascular-Kidney-Metabolic Syndrome, Heart, Lung and Circulation - Australia
2024 - 2025 Editor Special Issue Editor, Role of Colchicine in Atherosclerosis, Frontiers in Cardiovascular Medicine - Switzerland
2024 - ongoing Editor International Editorial Board Member, JRSM Cardiovascular Disease - United Kingdom
2018 - ongoing Board Member Cardiovascular Research - United Kingdom
2017 - ongoing Board Member Cardiovascular Diagnosis and Therapy - China
2017 - ongoing Associate Editor Interventional Cardiology, Heart, Lung and Circulation - United States
2015 - 2016 Associate Editor General Cardiology, Heart, Lung and Circulation - Australia
2011 - ongoing Board Member Journal of Geriatric Cardiology - China

Date Office Name Institution Country
2021 - ongoing Co-lead, Lifelong Health Theme South Australian Health and Medical Research Institute (SAHMRI) Australia
2021 - ongoing Leader, Heart and Vascular Program South Australian Health and Medical Research Institute (SAHMRI) Australia
2020 - ongoing President Australian Atherosclerosis Society Australia
2019 - 2020 Scientific Program Chair, Annual Scientific Meeting Cardiac Society of Australia and New Zealand Australia
2019 - ongoing Principal Site Investigator, NHMRC-funded CAUGHT-CAD study Royal Adelaide Hospital Australia
2018 - ongoing Principal Site Investigator, NHMRC-funded CAUGHT-CAD study Royal Adelaide Hospital Australia
2017 - ongoing Head of Optical Coherence Tomography Imaging Core Laboratory South Australian Health and Medical Research Institute (SAHMRI) Australia
2016 - ongoing National Lead Investigator, CLEAR study ESPERION Therapeutics Australia
2016 - 2020 Deputy Leader, Heart Heath Theme South Australian Health and Medical Research Institute (SAHMRI) Australia
2015 - ongoing Co-director, Vascular Research Centre, Heart Health Theme South Australian Health and Medical Research Institute Australia
2015 - 2017 Site Investigator, CARAT study Royal Adelaide Hospital Australia

Connect With Me

External Profiles

Other Links